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 The purpose of this study was to examine the relationship between glycemic control, 
executive functioning, and health-related quality of life in pediatric type 1 diabetes, as well as the 
impact of sex and age on these variables.  Adolescents (N = 191) ages 12 to 18, both male and 
female, and their caregivers were asked to complete the Pediatric Quality of Life (generic form), 
the Comprehensive Executive Functioning Inventory, and to provide demographic and medical 
history information.  Recent HbA1c, the number of diabetic ketoacidosis episodes, the number of 
hospitalizations, and a history of ketones, seizures, and hypoglycemia were obtained from the 
participant’s medical record to assess glycemic control. 
 Results indicated that executive functioning was a significant predictor of the variance of 
self-report health-related quality of life.  When glycemic control was added to the model, 
executive functioning also significantly predicted parent-report health-related quality of life.  
Additionally, glycemic control, executive functioning, and health-related quality of life were 
found to significantly covary with one another.  Moreover, there were significant negative 
correlations between HbA1c, number of DKA episodes, number of hospitalizations in the past 6 
months, number of hospitalizations since diagnosis and executive functioning.  Regarding 
glycemic control and quality of life, there were significant negative correlations between HbA1c, 
number of DKA episodes, hospitalizations in the past 6 months, and hospitalizations since 
diagnosis with health-related quality of life scales.  Finally, there were significant positive 
correlations between all executive functioning scales and all health-related quality of life scales.  
Of note, child’s current age did not predict nor was it significantly associated with glycemic 





hospitalizations and emotion regulation, but did not predict executive functioning or glycemic 
control.  Results demonstrate the importance of considering executive functioning when 
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  As advances in medicine become common practice, chronic illnesses are no longer an 
automatic death sentence.  Due to earlier detection and more effective treatments, millions of 
adults and children in the United States live with chronic illnesses.  Research indicates that 
chronic illness can cause significant stress and can lead to emotional, behavioral, and social 
problems (Dantzer, Swendsen, Maurice-Tison, & Salamon, 2003; Kakleas, Kandyla, Karayianni, 
& Karavanaki, 2009; Puri, Sapra, & Jain, 2013).  As a result, health-related quality of life 
(HRQoL) has become an important area of research and clinical practice.  HRQoL is the degree 
to which a medical condition impacts an individual’s physical, emotional, social, and mental 
functioning (Varni & Limbers, 2009).  Measuring HRQoL can provide clinicians with a picture 
of an individual’s functioning, as well as provide targets for prevention and intervention on the 
individual and global level.  Moreover, the United States government made monitoring and 
increasing HRQoL a public health goal with the Healthy People 2000, 2010, and 2020 initiatives 
(Office of Disease Prevention and Health Promotion, 2015).   
 One of the most common chronic illnesses is type 1 and type 2 diabetes (Centers for 
Disease Control, 2014).  Diabetes management is critical to optimal physical and mental 
functioning, while poor glycemic control can result in organ failure, seizures, and death (Centers 
for Disease Control, 2014).  Furthermore, research indicates that executive functioning is 
impaired in individuals with type 1 diabetes who have worse glycemic control (Galliot, 2008).  
Executive functioning includes a variety of cognitive processes that aid in decision-making and 
goal-directed behavior, such as attention, working memory, planning, and self-regulation 





adherence and disease management in those with chronic illnesses, including diabetes (Galliot, 
2008).  Although research indicates that greater treatment adherence and symptom management 
is associated with better HRQoL in those with type 1 diabetes, the interplay between executive 
functioning, HRQoL, and glycemic control has not been investigated.    
Purpose of the Study 
The purpose of this study is to add to what is known about HRQoL and pediatric type 1 
diabetes in relation to health outcomes and executive functioning.  Poor glycemic control in 
individuals with type 1 diabetes can negatively impact HRQoL and executive functioning.  In 
turn, deficits in executive functioning can decrease glycemic control and treatment adherence in 
those with type 1 diabetes.  Little is known about the relationship between HRQoL and executive 
functioning.  The interrelationship between these three global variables or specific components 
within these broader domains has not yet been explored.  To address this significant gap in the 
empirical literature, this study will examine the relationship between executive functioning, 
glycemic control, and HRQoL in adolescents with type 1 diabetes.  Assessing the relationship 
between these factors can aid in the identification of areas for prevention and intervention that 
can improve medical outcomes for children and adolescents with type 1 diabetes.  The 
hypothesized model (Figure 1) examines the relationship between age, gender, executive 
























Notes. Hba1c = glycated hemoglobin; DKA = diabetic ketoacidosis; CEFI = Comprehensive 
Executive Function Inventory; HRQoL = health-related quality of life; PedsQL= Pediatric 





1. Does age predict glycemic control? 
• Based on previous research, it is hypothesized older age will predict worse 
glycemic control (higher HbA1c, more hospitalizations, more  
episodes of diabetic ketoacidosis (DKA), and more seizures) due to the 
increased responsibility for diabetes management in adolescence. 
2. Is age correlated with executive functioning? 
Glycemic control: 
HbA1c 
# of hospitalizations 
# of DKA episodes 
History of seizures 
History of ketones 
Health-Related 













• Research indicates executive functioning improves with age. It is 
hypothesized age will significantly correlate with executive functioning, with 
older age associated with better executive functioning. 
3. Does the child’s sex predict glycemic control? 
• Previous research suggests females have worse glycemic control in pediatric 
diabetes; as a result, it is hypothesized female sex will predict worse glycemic 
control (higher HbA1c, more hospitalizations, more episodes of DKA, more 
seizures). 
4. Does the child’s sex predict executive functioning? 
• Based on previous findings, it is hypothesized that male sex will be associated 
with more executive functioning difficulties (lower scores on the CEFI). 
5. Is executive functioning correlated with glycemic control?   
• It is hypothesized that executive functioning (Full Scale score from the CEFI) 
will negatively correlate with glycemic control (higher HbA1c levels), greater 
numbers of hospitalizations, greater number of DKA episodes, and history of 
seizures based on previous research.  
• It is hypothesized that the CEFI subscales will correlate with glycemic 
control; with greater deficits associated with poorer glycemic control (higher 
HbA1c levels), greater number of hospitalizations, greater number of DKA 
episodes, and history of seizures based on previous research findings.   





• It is hypothesized executive functioning as measured by the Full Scale score 
on the CEFI predicts HRQoL (Total Scale Score, Physical Health Summary 
Score, and Psychosocial Health Summary Score). 
7. Does glycemic control correlate with HRQoL? 
• It is hypothesized that there will be a significant direct correlation between 
HbA1c, number of hospitalizations, number of DKA episodes, history of 
seizures, and HRQoL.  Lower HbA1c levels (better glycemic control) are 
hypothesized to negatively correlate with higher health-related quality of 
life (Total Scale Score, Physical Health Summary Score, and Psychosocial 
Health Summary Score). Higher numbers of hospitalizations, higher 
numbers of DKA episodes, and a history of seizures are hypothesized to 
negatively correlate with higher health-related quality of life (Total Scale 
Score, Physical Health Summary Score, and Psychosocial Health 
Summary Score). 
8. Is the hypothesized model a good fit for the data? 
•   It is hypothesized that in the proposed model executive functioning will 
predict HRQoL and covary with glycemic control.  It is also hypothesized 
that glycemic control covary with HRQoL. 
 
Definition of Terms 
HbA1c:  Glycated hemoglobin or HbA1c is generally used as a measure of an individual’s 
average blood sugar levels over a period of weeks or months.  Unlike blood glucose levels, 





diabetes frequently have their HbA1c measured to gauge their level of diabetes control.  HbA1c 
is also commonly referred to as A1c.   
 
Quality of Life:  Quality of life refers to the general well-being and welfare of an individual, a 
group of people, or a society.  Quality of life can be measured by examining the wealth, 
employment, environment, physical health, mental health, education, leisure time, and social 
connectedness of an individual, group, or society.  
 
Health Related Quality of Life:  Health-related quality of life or HRQoL measures the degree to 
which a chronic illness, health condition, or disease impacts the physical, psychological, 
cognitive, and social functioning of the effected individual. 
 
Executive Function:  Executive functioning refers to a system of cognitive processes that aid in 
goal directed behaviors.  Executive functioning processes include attention, inhibition, self-
regulation, organization, working memory, planning, mental flexibility, self-monitoring, and 
initiation of tasks.  Executive functioning is associated with the prefrontal cortex and develops 






Type 1 Diabetes 
One of the most common chronic illnesses is diabetes.  In America, an estimated 9.3% of 
the population, or 29.1 million people, have type 1 or type 2 diabetes, while approximately 
208,000 children under the age of 20 are currently diagnosed with either type 1 or type 2 diabetes 
(Centers for Disease Control, 2014).  Furthermore, approximately 1.25 million American adults 
and children have type 1 diabetes, with an estimated 18,436 children were diagnosed with type 1 
diabetes from 2008 to 2009 (Centers for Disease Control, 2014).  Type 1 diabetes, which is 
commonly referred to as juvenile-onset diabetes, is generally diagnosed in childhood or 
adolescence (Craig et al., 2014).  Type 1 diabetes is an incurable autoimmune disorder that 
occurs when the immune system destroys beta cells in the pancreas, which leads to deficits in 
insulin production and a build-up of glucose in the bloodstream.  Insulin is an essential hormone 
that signals cells to absorb sugar for fuel and helps maintain blood sugar levels (Craig et al., 
2014).  Blood sugar levels that are too low (hypoglycemic episode) or too high (hyperglycemic 
episode) have been implicated in several long-term medical complications, increased emergency 
room visits, increased medical costs, and even death.  On the other hand, better glycemic control 
has been found to reduce the risks for these negative effects (Wysocki et al., 2008).  In order to 
maintain good glycemic control, individuals with type 1 diabetes must monitor their blood sugar 
levels throughout the day, administer insulin via injection or a pump, maintain a healthy diet, and 
engage in exercise.  The management of type 1 diabetes can be time consuming, painful, and 





generally the main goal for those with type 1 diabetes and is essential to optimal physical, 
psychological, and cognitive functioning.  
 Type 1 diabetes can contribute to a number of medical, cognitive, and psychological 
difficulties.  Potential negative health outcomes associated with type 1 diabetes include renal 
failure, cardiovascular issues, nerve damage, kidney damage, blindness, limb amputation, and 
seizures (Craig et al., 2014).  In 2011, 21.9% of adults with type 1 or type 2 diabetes also had 
coronary heart disease, while 9.1% had experienced a stroke (Centers for Disease Control, 2014).  
Diabetes is currently the main cause of kidney failure, adult onset blindness, and lower limb 
amputations and has been found to lower life expectancy by up to fifteen years.  Furthermore, in 
2010, type 1 and type 2 diabetes was the seventh leading cause of death in the United States, 
which may be an underrepresentation.  Finally, it is estimated that in 2012, the economic cost for 
diagnosed diabetes in the United States was $245 billion (Centers for Disease Control, 2014).  
Overall, diabetes can take a serious and potentially deadly toll on an individual’s health and can 
result in increased hospitalizations, greater medical costs, and a plethora of medical problems.   
 Additionally, type 1 diabetes has been found to be associated with neurological deficits, 
such as lower grey matter volumes in the cerebellum, temporal-occipital cortex, and thalamus, as 
well as cerebral edema, and neuronal damage in the hippocampus and other brain areas 
(Arbeleaz, Semenkovich, & Hershey, 2013; Bjorgaas, 2012; Mauras et al., 2015).  Furthermore, 
cognitive deficits in intelligence, memory, processing speed, visuospatial abilities, psychomotor 
efficiency, and verbal skills have been found to be associated with type 1 diabetes to varying 
degrees (Biessels, Deary, & Ryan, 2008; Bjorgaas, 2012).  Impaired cognitive functioning in 
individuals with type 1 diabetes is associated with poorer glycemic control, vascular 





2008; Parent, Wodrich, & Hasan, 2009).  Moreover, individuals with type 1 diabetes may be 
particularly sensitive to cognitive impairments due to glycemic instability during childhood 
when brain structures are forming, and later in life when neurodegeneration occurs (Biessels et 
al., 2008).  These cognitive deficits may contribute to the academic difficulties and lower school 
achievement often found in youth with type 1 diabetes (Dahlquist, & Kallen, 2007; Hannonen et 
al., 2012; Hannonen et al., 2010).  More specifically, studies have demonstrated that youth with 
type 1 diabetes have significantly lower grades compared to non-diabetic peers (Dalquist & 
Kallen, 2007; Meo et al., 2013).  Moreover, one study found that youth with type 1 diabetes 
attained lower levels of education over time compared to non-diabetic controls (Wennick, 
Hallstrom, Lindgren, & Bolin, 2011).  Due to problems in diabetes management, it may be that 
those with type 1 diabetes have difficulties staying in school, are absent more often, and thus, 
their academic achievement suffers (Hannonen et al., 2012).  The cognitive and academic 
deficits associated with type 1 diabetes make these domains a necessary point for monitoring, 
prevention, and intervention.  
 Finally, research indicates those with type 1 diabetes are at an increased risk for poorer 
psychological outcomes, such as increased rates of depression and anxiety (Dantzer et al., 2003).  
Grey, Whittemore, and Tamborlane (2002), found that youth with type 1 or type 2 diabetes were 
approximately two to three times more likely to be diagnosed with depression than those without 
diabetes. A study conducted by Goldney, Philips, Fisher, and Wilson (2004) with 3,010 youth 
aged 15 and younger with and without type 1 diabetes yielded prevalence of depression in those 
with diabetes as 24% as opposed to 17% in non-diabetic youth.  In a ten-year longitudinal study, 
Kovacs, Goldston, Obrosky, and Bonar (1997) found that almost half of the youth with pediatric 





depression.  Depression has been linked to a plethora of negative consequences, such as poor 
social outcomes, poor school performance, and the need for greater medical or psychological 
treatment.  Not only is depression harmful and costly in itself, but internalizing disorders also 
have been found to be associated with adherence problems to diabetes regimens, poor glycemic 
control, increased hospitalizations, and greater risk for mortality (Delamater, 2009; Hood et al., 
2011).  Therefore, treating the depression and other comorbid psychological disorders present in 
individuals with type 1 diabetes is not only essential for psychosocial development, but also for 
health outcomes and cost management.  Although type 1 diabetes is not often associated with 
behavioral disorders, research indicates that behavioral problems contribute to poor diabetes 
control in adolescents (Northam et al., 2005).  This association may be due to the underlying 
deficits in inhibition, planning, and attention associated with poor glycemic control and 
externalizing disorders. 
Health-Related Quality of Life and Diabetes 
 Health-related quality of life has become an emerging field of study in pediatrics and 
health research (Polonsky, 2000; Varni & Limbers, 2009).  Health-related quality of life 
(HRQoL) is the “extent to which a disease or medical condition impacts upon the daily physical, 
emotional, and contextual well-being of an individual” (Cameron, 2003, p.132).  In other words, 
health should not be examined solely through the lens of whether or not an illness or disease is 
present, but also by physical, psychological, mental, and social functioning (Rubin & Peyrot, 
1999).  Current measures of HRQoL examine global and disease-specific domains, in order to 
understand the general and specific impacts of illness (Rubin & Peyrot, 1999; Varni & Limbers, 
2009).  For example, diabetes-specific quality of life (DSQoL) measures provide more detailed 





symptoms (Lawrence et al., 2012; Varni & Limbers, 2009).  It is essential that practitioners 
utilize both global and disease-specific measures of HRQoL to tap into various elements 
associated with general illness and specific illnesses in order to improve patient care and the field 
of knowledge (Rubin & Peyrot, 1999; Varni & Limbers, 2009).   
 Research indicates that childhood chronic illnesses can have a significant negative impact 
on a child’s HRQoL (Delamater et al., 2001; Hood, Rausch, & Dolan, 2011; Nardi et al., 2008).  
The added stress, responsibility, and isolation associated with chronic illness can exacerbate the 
developmental and psychosocial adjustment problems children already face while growing up 
(Polonsky, 2000).  More specifically, it has been found that children and teens with type 1 
diabetes experience lower life satisfaction, lower health perception, lower levels of generic 
HRQoL, and greater incidences of depression and anxiety than peers without diabetes (Faulkner, 
2003; Goldney et al., 2004; Hood, Rausch, & Dolan, 2011; Kalyva, Malakonaki, Eiser, & 
Mamoulakis, 2010; Nardi et al., 2008; Sundber, Sand, & Forsander, 2014).  Poorer quality of life 
is associated with adherence problems to diabetes regimens, poor glycemic control, increased 
hospitalizations, and poor coping strategies (Delamater, 2009; Graue et al., 2004; Hood et al., 
2011; Penckofer et al., 2012).  On the other hand, good glycemic control has been found to be 
associated with better quality of life in most studies (Hoey et al., 2001; Reid et al., 2013).  
Quality of life and glycemic control may have a reciprocal relationship whereby when one area 
worsens so does the other.  Kalyva, Malakonaki, and Mamoulakis (2011) found that later age of 
onset of diabetes, less hyperglycemic episodes, lower HbA1c, older age, and being male were 
associated with better diabetes-specific and general HRQoL.  Moreover, in a study of 325 
children with type 1 diabetes and their parents, fear of a hypoglycemic episode was found to be 





on a possible point for intervention.  These studies highlight the importance of examining quality 
of life as it relates to the patient’s medical and psychological functioning.  Due to the substantial 
impact HRQoL can have on diabetes management and health outcomes, it is imperative that 
clinicians measure and monitor patient quality of life.  Clinicians should attempt to obtain parent 
and child reports when feasible because gaining perspectives from multiple informants can 
provide a clearer picture of child functioning (Eiser & Varni, 2013).  Overall, data gathered from 
HRQoL measures can aid in the creation and modification of interventions and treatments that 
are more effective, targeted, feasible, and can aid in alleviating functional impairments in the 
patient’s daily life. 
 Age differences in HRQoL in pediatric type 1 diabetes 
 Furthermore, as children develop into adolescents and begin to take greater 
responsibility for their diabetes management, it is particularly important to monitor quality of 
life.  In general, adolescents tend to report more symptoms of depression and anxiety compared 
to children in both diabetic and healthy populations (Hanberger, Ludvigsson, & Nordfeldt, 2009; 
Hoey et al, 2001; Nardi et al., 2008; Wagner et al., 2005).  For example, Nardi et al. (2008) 
studied 70 youth with type 1 diabetes ranging in age from 6 to 18.  Results indicated that prior to 
adolescence, children with type 1 diabetes did not report lower quality of life, more feelings of 
social isolation, or more behavioral or psychological problems.  As children developed into 
adolescents, there was a significant increase in parent and self-reported symptoms of 
psychological and behavioral problems, such as depression, anxiety, and defiance.  Moreover, 
depressive and anxiety symptoms were found to contribute to lower quality of life (Nardi et al., 
2008).  Wagner et al. (2005) also found that in 68 children and adolescents with type 1 diabetes, 





depression and anxiety.  Adolescence may be a key time to monitor quality of life due to the 
bodily changes that occur, as well as the new identities and responsibilities that are being 
explored.  Finally, the transition from parent to youth management of diabetes can contribute to 
an increase in diabetes-specific family conflict, which has been shown to decrease HRQoL 
(Laffel et al., 2003; Reid et al., 2013) and worsen glycemic control (Rohan et al., 2014).  
Targeting this transitional period and the communication between parents and youth may have 
positive outcomes for diabetes management and HRQoL in this population.   
 Sex differences in HRQoL in pediatric type 1 diabetes 
 Research indicates sex may also contribute to self and parent-reported HRQoL in 
pediatric type 1 diabetes.  In a study by Lawrence et al. (2012), female sex was negatively 
associated with HRQoL, while Hanberger, Ludvigsson, and Nordfeldt (2009) found females with 
type 1 diabetes and their parents reported lower HRQoL than males in both childhood and 
adolescence.  Additionally, in a study conducted by Hilliard et al. (2013), male sex predicated 
improvements in HRQoL over 1 year, while Kalyva et al. (2011) reported better HRQoL and 
diabetes-specific HRQoL for adolescent males compared to adolescent females.  Moreover, 
research by Naughton et al. (2014) indicates HRQoL improves over time in males with pediatric 
type 1 diabetes, but remains the same or decreases for females with pediatric type 1 diabetes.  
Sex differences in parent and self-reported HRQoL in youth with type 1 diabetes may be 
explained by girls experiencing psychological adjustment problems at an earlier age and the 
higher rates of depression and anxiety in females with or without diabetes (Faulkner, 2003; 
Hanberger, Ludvigsson, and Nordfeldt, 2009; Hoey et al., 2001).  Due to the significant 





HRQoL and emotional adjustment, female youth with type 1 diabetes may need extra monitoring 
and support.  
Glycemic Control  
 Metabolic or glycemic control involves keeping blood glucose levels as close to normal 
as possible through diet, exercise, medication, and insulin among other strategies (American 
Diabetes Association, 2013).  Glycemic control is generally the main goal of diabetes 
management because fluctuations in blood sugar levels may contribute to serious health 
complication and even death (American College of Endocrinology, 2002; Hannonen et al., 2003; 
Juarez et al., 2012; Rewers et al., 2014).  Generally, glycemic stability is measured by 
Hemoglobin A1c or HbA1c or A1c, which provides an average of blood glucose levels over a 
period of time (American Diabetes Association, 2013; American College of Endocrinology, 
2002; Rewers et al., 2014).  An optimal glycemic level is defined as an HbA1c level less than 
7% (58 mmol/mol) for children and adolescents (American Diabetes Association, 2010; Rewers 
et al., 2014).  Glycemic instability can result in hypoglycemia, hyperglycemia, or DKA.  
Hypoglycemia occurs when blood sugars are lower than normal levels, while hyperglycemia is 
when blood sugar levels are higher than normal levels (Rewers et al., 2014).  Severe 
hypoglycemia can result in seizures, loss of consciousness, and even death (Mayo Clinic, 2012).  
On the other hand, complications associated with hyperglycemia include cardiovascular disease, 
nerve damage, kidney damage, retina damage, and joint problems. (Mayo Clinic, 2015).  If 
hyperglycemia is present over an extended period of time, DKA can occur.  DKA is when the 
body breaks down fat for energy, which results in the production of toxic acids or ketones.  





unchecked glycemic variation in type 1 diabetes can have devastating physical and medical 
consequences. 
Glycemic control and HRQoL  
 The instability and consequential physical ailments associated with glycemic variability 
in diabetes can also impact HRQoL and diabetes-specific quality of life (DSQoL; Ayano-
Takahara et al., 2015; Penckofer et al., 2012; Tahirovic et al., 2012).  Glycemic instability in 
adolescents with type 1 diabetes is associated with lower physical and mental health, greater 
burden associated with diabetes, less self-efficacy, and a more negative viewpoint on diabetes 
and their ability to adhere to treatment (Viklund & Ortqvist, 2014).  In a study conducted by 
Lawes, Franklin, and Farmer (2014), researchers examined the HbA1c trajectories of 155 youth 
with type 1 diabetes for six months after diagnosis and found glycemic instability to be 
association with negative psychosocial factors, such as a major stressful life event or a diagnosis 
of a mental illness.  Moreover, Lawrence et al. (2012) found that lower QoL is associated with 
depressive symptoms and more glycemic instability.  In a longitudinal study conducted over an 
average of 23.5 years, 1,441 participants with type 1 diabetes, ranging in age from 13 to 65, were 
examined (Jacobson et al., 2013).  Researchers found that poor metabolic control, medical 
complications associated with diabetes (i.e., severe hypoglycemia, incontinence, erectile 
dysfunction, blindness), and depressive symptoms decreased HRQoL.  Furthermore, in a study 
conducted by Hood et al. (2014), researchers found that among 1,307 youth with type 1 diabetes, 
the first six years after diagnosis was a time of great glycemic instability.  Lower DSQoL 
predicted worse glycemic control over time, but generic QoL did not, while participants who 
viewed diabetes as a negative impacting factor on their daily life, social life, and academic 





of DSQoL such as disease management and psychosocial functioning have been found to 
differentiate between those who have poor or stable glycemic control.  Ingerski, Laffel, Drotar, 
Repaske, and Hood (2010) examined the glycemic levels and DSQoL of 261 youth with type 1 
diabetes.  Results indicated that that DSQoL and glycemic levels were negatively correlated, 
with higher DSQoL scores being associated with lower A1c.  Moreover, family functioning and 
depression were found to contribute to glycemic control and DSQoL. 
 Conversely, research indicates that there is a significant association between 
improvements in HbA1c and improvements in psychological facets of QoL in adults with type 1 
diabetes (Lau, Qureshi, & Scott, 2004).  Abbatecola et al. (2014) found that in older adults with 
diabetes, improvements in glycemic control over time correlated with an increase in reported 
DSQoL.  Furthermore, Weinger and Jacobson (2001) delivered an intensive diabetes education 
intervention to 55 adults with type 1 diabetes.  Results indicated that improvements in glycemic 
control were associated with an increase in satisfaction with diabetes treatment, a facet of 
DSQoL and a factor that may contribute to treatment adherence.  This study highlights the 
potential utility of educational interventions in diabetes care for reducing glycemic instability 
and improving QoL.  Overall, glycemic control appears to have a significant impact on both 
generic QoL and DSQoL and vice versa.  
Glycemic control and executive functioning 
Glycemic instability has also been found to contribute to impairments in cognitive 
functioning (Kinga & Szamoskozi, 2014).  Throughout childhood, the brain develops and 
requires massive amounts of energy.  As a result, the developing brain may be more sensitive to 
glycemic fluctuations, such as those that occur in type 1 diabetes (Arbelaez, Semenkovich, & 





functioning in youth with type 1 diabetes (McCrimmon, Ryan, & Frier, 2012).  For example, 
frequency of hyperglycemia was found to be associated with deficits in executive functioning, 
learning, memory, and overall intelligence in children with type 1 diabetes when compared to 
healthy controls (Cato et al., 2014).  Furthermore, Patino-Fernandez et al. (2010) found that in 
preschool age children with type 1 diabetes, poor glycemic control was associated with lower 
cognitive abilities in general, including slower fine motor speed and lower receptive language.  
In another study, deficits in verbal intelligence were influenced by episodes of hyperglycemia, 
while problems with spatial intelligence and long-term recall were associated with hypoglycemia 
(Pernatie et al., 2008).  Hyperglycemia also has been linked to deficits in long-term spatial 
memory (Malone et al., 2008), as well as learning and memory consolidation (Northam et al., 
1999; Nylander et al., 2012).  Severe recurrent episodes of hypoglycemia also have been 
implicated in studies examining visuospatial functioning and motor speed (Desrocher & Rover, 
2004; Lin et al., 2010), as well as phonological processing and short-term memory (Hannonen et 
al., 2003; Lin et al., 2010).  Additionally, during acute hypoglycemia, deficits in verbal memory, 
visual memory, working memory, delayed memory, visual-motor ability, and visual-spatial skills 
have been observed (Kodl & Seaquist, 2008).  Although acute hypoglycemia may be more 
fleeting, it may negatively impact the acquisition of academic skills in younger children if it 
occurs at school (Kodl & Seaquist, 2008).   
On the other hand, Musen et al. (2008) studied 249 adolescents with diabetes who were 
monitored for 6 years.  Participants were not found to have a decline in cognitive function over 
this time period.  Furthermore, Ly et al., (2011) in a 16-year longitudinal study did not find any 
significant differences on general intelligence or memory between youth with type 1 diabetes 





tasks of executive functioning that included set shifting, concept formation, and problem solving, 
with youth with diabetes performing worse.  Moreover, although Ohmann et al. (2010) did not 
find any cognitive differences between adolescents with type 1 diabetes and controls, there were 
significant differences between groups in cognitive flexibility, planning, and concept formation.  
Across several studies, hypoglycemia has been implicated as a factor associated with deficits in 
attention, working memory, planning, and problem-solving (Asvold, Sand, Hestad, & Bjorgaas, 
2010; Bjorgaas, Gimse, Vik, & Sand, 1997; Cato et al., 2014; Graveling, Deary, & Frier, 2013; 
Hannonen, Tupola, Ahonen, & Riikonen, 2003; Lin et al., 2010; Ly et al., 2011; Rovet & 
Alvarez, 1997; Rovet & Ehrlich, 1999; Ryan et al., 1990; Sommerfield, Deary, McAulay, & 
Frier, 2003; Strudwick et al., 2005).  Furthermore, hyperglycemia and DKA are also associated 
with deficits in attention and working memory (Cameron et al., 2014; Cato et al., 2014; Lin et 
al., 2010; Shehata & Eltayeb, 2010).  Overall, glycemic instability can have an aversive impact 
on cognitive functioning and executive functioning in particular.  
Age differences in glycemic control in pediatric type 1 diabetes 
Research indicates age of diagnosis can impact glycemic control in pediatric type 1 
diabetes, as well as age factors can affect HbA1c throughout the lifespan (Forga et al., 2013).  
Diagnosis at a later age is related to poorer glycemic outcomes, while diagnosis of type 1 
diabetes at a younger age is associated with better controlled HbA1c.  Additionally, youth with 
an onset of type 1 diabetes in adolescence demonstrate poorer metabolic control compared to 
those diagnosed in childhood (Forga et al., 2013; Levine et al., 2001). Earlier diagnosis may be 
related to better adjustment and knowledge about diabetes management.  On the other hand, 
some research has found that longer duration of diabetes is associated with worse glycemic 





diabetes, researchers found higher HbA1c was significantly correlated with longer duration of 
diabetes, female gender, and adolescence (Hanberger, Samuelsson, Lindblad, and Ludvigsson, 
2008).  
As children move into adolescence, research also indicates HbA1c often worsens. 
Adolescent have higher incidents of DKA, hypoglycemia, and diabetes-related hospitalizations 
compared to adults (Acerini, Williams, & Dunger, 2001; Forga et al., 2013, Levine et al., 2001).  
Declines in glycemic control in adolescence may be due to the important hormonal and 
physiological changes that occur (Acerini et al., 2001), as well as the increased responsibility for 
diabetes management in adolescence (Lawes, Franklin, & Farmer, 2014).  Moreover, 
psychosocial distress has been found to be correlated with poorer glycemic control and type 1 
diabetes outcomes (Viklund & Ortqvist, 2014).  As adolescents are more likely to experience 
higher rates of psychosocial distress and mental health issues, this may play a role in their 
increased risk for poorer glycemic control (Lawes et al., 2014; Lawrence et al., 2012).  
Sex differences in glycemic control in pediatric type 1 diabetes 
Sex of the individual has been implicated as potential factor impacting HbA1c, metabolic 
control, and type 1 diabetes-related health outcomes.  Across studies, being female is associated 
with higher A1c (Hanberger et al., 2008).  In a study of 8,020 youth with type 1 diabetes, 
researchers reported girls on average had higher HbA1c at diagnosis and at follow-up compared 
to males (Hanberger, Akesson, and Samuelsson, 2013).  Another study also found that female 
adolescents with type 1 diabetes had higher initial HbA1c at diagnosis and over time, compared 
to adolescent males with type 1 diabetes, up until young adulthood (Samuelsson et al., 2016).  
Rohan et al. (2013) found that sex was a significant factor in glycemic control over a 3-year 





diabetes-related complications.  Additionally, Elsamahy, Elhenawy, and Altayeb (2017) 
concluded female youth with type 1 diabetes had worse HbA1c over 4 years and required higher 
insulin dosages 8 and 10 years after diagnosis compared to males with type 1 diabetes.  Sex 
differences in glycemic control may be due to hormonal and psychosocial differences between 
males and females that impact HbA1c (Lawrence et al., 2012).  
Executive Functioning, Type 1 Diabetes, and Glycemic Control 
 Executive function is a term that subsumes a variety of abilities that reflect cognitive 
processes such as attention, organization, working memory, reasoning, task flexibility, planning, 
behavioral and emotional self-regulation, and problem solving (Galliot, 2008; McNally, Rohan, 
Shroff-Pendley, Delamater, & Drotar, 2010).  Executive functioning develops as children age 
and is associated with the prefrontal cortex.  Optimal executive functioning produces self-
regulation and persistence, as well as better decision-making, school performance, mental health, 
and relationships outcomes (Galliot, 2008).  Furthermore, research indicates that executive 
functioning oftentimes plays a substantial role in treatment adherence, glycemic control, and 
diabetes management (McNally et al., 2010; Rasmussen, Ward, Jenkins, King, & Dunning, 
2010; Smith, Kugler, Lewin, Duke, & Storch, 2014), especially when treatment regimens are 
more intense or require multiple steps (Graziano et al., 2011; Nguyen et al., 2010; Primozic, 
Tavcar, Avbelj, Zvezdana-Dernovsek, & Ravnik Oblak, 2011; Smith et al., 2014).  The 
management of diabetes often includes dietary restrictions, frequent blood glucose monitoring, 
and insulin administration (Bagner, Williams, Geffken, Silverstein, & Storch, 2007).  These tasks 
require the patient to employ behavioral self-regulation, attention, working memory, planning, 
and problem solving in order to achieve optimal treatment.  Bagner et al. (2007) explored the 





diabetes regimens.  Results indicated that in 130 youth with type 1 diabetes, executive 
functioning predicted diabetes treatment adherence.  Furthermore, McNally et al. (2010) 
researched 235 children with type 1 diabetes and their self and parent ratings of executive 
functioning, diabetes treatment adherence, and glycemic control.  Researchers found that 
executive functioning facets, such as planning, problem solving, organization, self-regulation, 
and working memory, contributed to better treatment adherence and metabolic control (McNally 
et al., 2010).  Finally, in a study by Smith et al. (2014), adherence to diabetes regimens 
moderated the relation between executive functioning and glycemic control.  Due to the 
cognitive requirements associated with diabetes management, executive functions are essential to 
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Notes:  EF = executive functioning; HRQoL = health-related quality of life; QoL = quality of 
life; HbA1c = glycated hemoglobin; DKA = diabetic ketoacidosis; BRIEF = Behavior Rating 




Although diabetes treatment adherence, management, and glycemic control may be 
impacted by executive functions, glycemic control also appears to influence executive 
functioning.  Executive functioning requires large amounts of glucose to operate properly 
(Galliot, 2008).  Variations in glycemic control, such as a hypo- or hyperglycemic event, appear 
to have a negative impact on executive functioning (Bade-White & Obrzut, 2009; Cato et al., 
2014; Graveling, Deary, & Frier, 2013).  Specifically, executive functioning operations such as 
working memory, attention, decision-making, planning, and mental flexibility have been 
determined to be especially vulnerable to the deleterious effects of hypoglycemic episodes 
(Bade-White & Obrzut, 2009; Rovet & Alvarez, 1997).  Further, extreme glycemic fluctuations 
in childhood and adolescence may have an even greater impact on executive functioning due to 
the sensitivity of the developing brain (Arbelaez, Semenkovich, & Hershey, 2013; Bade-White 
& Obrzut, 2009; Biessels, Deary, & Ryan, 2008; Bjorgaas, 2012; Brismar et al., 2007; Gaudieri, 
Chen, Greer, & Holmes, 2008).  Because of the potential negative consequences of glycemic 
fluctuations on executive functioning, it is imperative that blood glucose levels are monitored to 
prevent cognitive impairment.  Most of the current research on executive functioning in pediatric 
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type 1 diabetes focuses on attention, working memory, self-regulation, and problem solving or 
planning.   
 Attention in pediatric type 1 diabetes 
 Attention is the ability to selectively focus on a stimuli or aspect of information, while 
ignoring other information.  Attention is often conceptualized as being composed of three 
components: alerting, orienting, and executive attention (Anderson, 2010; Geva, Zivan, Warsha, 
& Olchik, 2013).  Alerting is the ability to maintain a state of sensitivity or vigilance to incoming 
stimuli and information, while orienting is the ability to select necessary or relevant sensory 
information (Visintin et al., 2015).  Moreover, executive attention is the ability to detect and 
resolve conflicting information or the ability to inhibit competing stimuli (Visintin et al., 2015).  
Research indicates that attention is often suboptimal in those with pediatric type 1 diabetes 
(Bade-White & Obrzut, 2009; Northam et al., 2005).  For example, Rovet and Alvarez (1997) 
studied 103 youth with type 1 diabetes in comparison to 100 healthy controls on measures of 
intelligence and attention.  Participants with type 1 diabetes demonstrated deficits in orienting, 
while children with early-onset diabetes performed worse on orienting tasks than those with 
later-onset diabetes.  Moreover, children with type 1 diabetes and a history of seizures performed 
significantly worse on tasks that required alerting and executive attention than those youth with 
type 1 diabetes without a history of seizures.  These results indicate not only differences in 
attentional capabilities between youth with and without type 1 diabetes, but also different 
attentional deficits based on age of onset for type 1 diabetes and a history of seizures.   
 Moreover, research has found an association between hypoglycemic episodes, age of 
onset, and deficits in attention.  Hannonen, Tupola, Ahonen, and Riikonen (2003) compared 





without a history of severe hypoglycemic and to healthy controls.  Although results were not 
statistically significant due to the small sample size, group differences were found on measures 
of attention, with youth with type 1 diabetes performing worse on tasks that measured attention.  
Furthermore, results indicated that youth with type 1 diabetes and severe hypoglycemic 
performed worse on cognitive and attention tasks than youth with type 1 diabetes without severe 
hypoglycemia.  Additionally, Bjorgaas, Gimse, Vik, and Sand (1997) examined cognitive and 
attentional differences between youth with type 1 diabetes with and without episodes of severe 
hypoglycemia and healthy controls.  Results indicated an association between early onset of type 
1 diabetes, severe hypoglycemic episodes, and attentional deficits.  Finally, in a meta-analysis 
that examined fifteen studies and included 2,144 children with type 1 diabetes and 751 controls, 
results indicated that children with type 1 diabetes demonstrated performance deficits on tasks of 
attention (Gaudieri, Chen, Greer, & Holmes, 2008) with earlier onset diabetes (i.e., before age 7) 
associated with greater deficits in attention.   
 Longitudinal research also has elucidated some of the effects of pediatric diabetes on 
attention.  Lin, Northam, Rankins, Werther, and Cameron (2010) examined youth with type 1 
diabetes and healthy controls over 12 years.  Researchers found that children with early-onset 
diabetes performed worse on tasks of sustained and divided attention compared to those with 
later onset diabetes and healthy controls.  Interestingly, frequency of hyper- and hypoglycemic 
episodes were not found to be associated with performance on tasks of attention.  In a seven-year 
longitudinal study, 16 children with type 1 diabetes were evaluated on various neurocognitive 
measures (Rovet & Ehrlich, 1999).  Participants with early-onset diabetes (before age 5) scored 
significantly lower on continuous attention performance tasks and youth with diabetes and a 





examined neurocognitive functioning in youth with type 1 diabetes and severe hypoglycemia 
over 18 months, results indicated that severe hypoglycemia was not associated with decreases in 
attention (Wysocki et al., 2003).  Although contrary to findings from other studies, the Wysocki 
et al. (2003) study may lend support to the theory that it is an interplay of factors (i.e., age of 
onset, hypoglycemic episodes, seizures, and so on) that affect attention, rather than one factor 
alone.  Overall, these studies highlight the detrimental impact that pediatric type 1 diabetes can 
have on attention; however, more longitudinal studies need to be conducted to elucidate how the 
interplay of diabetic complications and factors that affect attention over time.  
Working memory in pediatric type 1 diabetes 
 Working memory is the ability to hold and manipulate information for a short period of 
time and is essential for learning and problem solving (Sommerfield, Deary, McAulay, & Frier, 
2003).  Significant deficits in working memory have been found in youth and adults with type 1 
diabetes (Hannonen et al., 2003).  In a study that examined the cognitive performance of 105 
youth with type 1 diabetes and 75 healthy controls, researchers found that youth with type 1 
diabetes performed worse on working memory tasks compared to non-diabetic controls (Lin et 
al., 2010).  Moreover, poorer performance on tasks of working memory was associated with 
hypoglycemic episodes (Lin et al., 2010; Sommerfield et al., 2003).  More specifically, 
neuroimaging research indicated that severe hypoglycemia might cause synaptic and neuronal 
damage in the hippocampus, an area that is thought to contribute to working memory (Hershey et 
al., 2010; Schwartz, Wasserman, Powell, & Axelrad, 2014; Yamada et al., 2004).  Furthermore, 
Hershey et al. (2010), found that in youth with type 1 diabetes, hippocampal volumes were 
enlarged and associated with hypoglycemic episodes.  Larger hippocampal volumes may indicate 





and attention-deficit/hyperactivity disorder, disorders that are also prone to deficits in executive 
functioning (Hershey et al., 2010).  On the other hand, Strudwick et al. (2005), found that 
seizures or coma as a result of severe hypoglycemia in youth with pediatric type 1 diabetes were 
not associated with working memory deficits.  
 In contrast, hyperglycemic episodes have been linked to working memory deficits (Lin et 
al., 2010) and neuroanatomical differences in the cerebellum and medial pre-frontal cortex 
(Marzelli et al., 2014).  The cerebellum, particularly the superior-posterior cerebellum, and the 
pre-frontal cortex have been implicated in working memory, which may explain why 
neuroanatomical discrepancies in these areas may manifest as deficits in working memory 
(Marzelli et al., 2014).  Finally, DKA also has been found to be associated with significant 
performance deficits in working memory (Schwartz et al., 2014; Shehata & Eltayeb, 2010).  
DKA occurs when the body produces high levels of blood acids or ketones, due to an inability to 
produce insulin, which results in the breakdown of fat for fuel (Mayo Clinic, 2012).  Cameron et 
al. (2014), found that in youth with type 1 diabetes and DKA, white matter volume in the frontal 
lobe was enlarged due to cerebral edema.  Furthermore, this enlargement in the frontal lobe was 
associated with deficits in working memory, which is not surprising since this brain area is often 
associated with a variety of executive functions.  Overall, an array of potential side effects of 
pediatric type 1 diabetes, such as hypo- and hyperglycemic episodes, as well as DKA, have been 
implicated in suboptimal working memory.   
 Self-regulation in pediatric type 1 diabetes  
 Self-regulation involves the capacity to monitor and control emotions, thoughts, and 
behaviors and is often associated with inhibitory-control (Anderson, 2010).  Self-regulation is 





the maintenance of social relationships (Graziano et al., 2011; McNally et al., 2010; Schilling, 
Grey, & Knafl, 2002).  Berg et al. (2014) found that in 110 youth with type 1 diabetes, self-
regulation skills were associated with diabetes regimen adherence.  In fact, fluctuations in self-
regulation across days predicted the degree to which youth adhered to treatment.  Additionally, 
Rohan et al. (2011) found that youth with type 1 diabetes displayed distinct patterns of self-
management that contributed to glycemic control.  More specifically, higher levels of self-
management were associated with better HbA1c levels.   
 On the other hand, children with type 1 diabetes have been found to have significantly 
higher deficits in emotional control and behavioral regulation compared to non-diabetic peers 
(Caruso et al., 2014).  For example, Hughes, Berg, and Wiebe (2012) found that in adolescents 
with type 1 diabetes, problems with emotional processing, and low self-control, there was more 
glycemic instability.  Furthermore, research indicates that emotion regulation deficits are 
associated with poor treatment adherence and glycemic control in boys with type 1 diabetes, but 
not girls (Graziano et al., 2011).  This sex difference may be due to the fact that in general, boys 
exhibit more executive functioning deficits than girls, so this facet is less likely to impact 
adherence in females (Graziano et al., 2011).  Results of the Northam et al. (2001) study 
demonstrated decreases in self-monitoring ability six years after diagnosis for youth with type 1 
diabetes.  On the other hand, Miller et al. (2012), found that emotional regulation improved over 
a two-year period in adolescents with type 1 diabetes, which was associated with better self-
management and diabetes treatment adherence.  Surprisingly, Miller et al. (2012), found that 
neither executive functioning overall nor self-management specifically predicted glycemic 
control, but better self-regulation was associated with better metabolic control.  These disparate 





regulation.  Furthermore, executive function abilities, such as self and emotional-regulation 
develop through young adulthood; therefore, improvements in self-management as children age 
are not inconsistent with normal development.  Comparisons between youth with and without 
type 1 diabetes on measures of self-regulation may shed more light on the divergent findings in 
the current literature.  Finally, it also should be noted that research indicates that self-regulation 
leads to better glycemic control and treatment adherence (Bagner et al., 2007; Hughes, Berg, & 
Wiebe, 2012; McNally et al., 2010; Rohan et al., 2011).  Overall, the current literature supports 
the need for more research into how pediatric type 1 diabetes affects the development and 
maintenance of self-regulation, especially as this particular ability has implications for treatment 
adherence and quality of life. 
 Problem-solving and planning in pediatric type 1 diabetes 
The ability to problem-solve involves analysis of a problem or pattern, the weighing of 
various choices, the effective selection and implementation of a solution, and the evaluation of 
the chosen solution (Anderson, 2010; Rustad et al., 2013; Wysocki et al., 2008).  Problem 
solving has been found to be associated with academic, occupational, and social success 
(Wysocki et al., 2008).  Planning is often considered an element of problem solving and involves 
the integration of information to achieve a goal or solve a problem.  Furthermore, planning and 
problem solving have been found to be significantly impaired in children with type 1 diabetes 
(Brands, Biessels, De Haan, Kappelle, & Kessels, 2005; Northam et al., 2001).  In a 16-year 
longitudinal study, Asvold, Sand, Hestad, and Bjorgaas (2010) found that participants with type 
1 diabetes did significantly worse on tasks of problem solving compared to non-diabetic controls 
and these deficits were correlated with more incidents of severe hypoglycemia.  Moreover, in a 





problem solve in novel situations in those with type 1 diabetes, while Viklund and Ortqvist 
(2014) found that problem-solving ability helped in predicting variation in HbA1c stability in 
youth with type 1 diabetes.  Furthermore, induced hypoglycemia in children results in poorer 
performance on tasks related to planning and decision-making (Ryan et al., 1990), while severe 
hypoglycemia has been implicated in problem-solving deficits (Bjorgaas, 2012).  Additionally, 
episodes of hypoglycemia and seizures at a younger age appear to more significantly affect 
planning (Asvold et al., 2010; Ly, Anderson, McNamara, Davis, & Jones, 2011).  Enlargements 
found in the frontal lobe of youth with type 1 diabetes due to DKA also may be related to deficits 
in planning and problem solving (Cameron et al., 2014).  Finally, problem solving and planning 
have been found to contribute to better management of diabetes and adherence to treatment in 
some studies (Glasgow et al., 2007; King et al., 2010; McNally et al., 2010); Toobert & 
Glasgow, 1990), but not others (Hill-Briggs & Gemmell, 2007; Miller et al., 2012).  In 
conclusion, research on the problem solving and planning abilities of youth with type 1 diabetes 
is sparse.  Future research is needed in these areas, as deficits in problem solving and planning 
can have detrimental effects on treatment adherence, especially when children transition into 
adolescence and begin to take responsibility for diabetes management (Bagner et al., 2007).  
Sex differences in executive functioning 
There has been mixed evidence for sex differences in executive functioning.  In a study 
of 2,200 youth, Naglieri and Rojahn (2001) found that females performed better than males on 
tasks of planning and attention.  Behavioral inhibitory control has also been found to be better in 
females compared to males (Yuan et al., 2008), as well as self-regulation (Coyne, Vaske, 
Boisvert, & Wright, 2015).  On the other hand, other studies have found no significant 





Skurvydas, 2016) or working memory (Hill, Laird, & Robinson, 2014; Teleb & Al Awamleh, 
2012).  In contrast, some research has indicated that women perform better on verbal working 
memory tasks, while men perform better on visual-spatial working memory tasks (Harness et al., 
2008; Hill et al., 2014).  Overall, the literature is not clear on how sex potentially impacts 
executive functioning.  
Age differences in executive functioning 
Research indicates executive functioning improves throughout childhood and peaks in the 
mid to late 20’s, which may be due to the development of neural and cognitive networks over 
time (De Luca et al., 2003).  Executive functioning domains develop at different points in 
childhood and adolescence.  For example, attention appears to begin to develop in infancy and 
throughout early childhood, while cognitive flexibility, goal setting, and information processing 
grow exponentially up until 12-years-old. Additionally, executive functioning is further refined 
throughout adolescence and into adulthood (Anderson, 2002; De Luca et al., 2003).  
Furthermore, Brocki and Bohlin (2004) found that development of executive functioning occurs 
in three particularly active stages of development: ages 6 to 8, ages 9 to 12, and adolescence.  
Over time, executive functioning abilities improve with age and development.   
Quality of Life and Executive Functioning 
 Currently, there is very little research examining the connection between executive 
functioning and quality of life.  In a study conducted by Sherman, Slick, and Eyrl (2006), 
executive dysfunction adversely impacted HRQoL in children with epilepsy, while Neal et al. 
(2015) found that deficits in executive functioning were associated with poorer psychosocial 
health in adolescents with cyanotic congenital heart disease.  Moreover, de Vries and Geurts 





life was associated with deficits in executive functioning.  Specifically, parents reported that 
their child with ASD presented deficits in cognitive flexibility, emotional control, inhibition, 
working memory, planning, and organization, which contributed to a decreased quality of life in 
social, emotional, and academic functioning.  Laffond et al. (2011) found that in children with 
craniopharyngioma, or a benign tumor, symptoms of depression, executive functioning deficits, 
and lower quality of life were significantly correlated with each other.  Additionally, in a study 
that examined executive functioning and coping in adolescents and adults who sustained a 
traumatic brain injury (TBI), researchers found that better executive functioning was associated 
with more effective problem solving and coping (Krpan, Levine, Stuss, & Dawson, 2007).  
Furthermore, research indicates that deficits in executive functions, specifically set shifting and 
working memory, are associated with lower HRQoL in older women (Davis, Marra, Najafzadeh, 
& Liu-Ambrose, 2010).  Finally, self-management has been found to increase quality of life in 
adolescents with type 1 diabetes (Jaser et al., 2012), while improvements in executive 
functioning are correlated with increases in HRQoL in adults with attention-deficit/hyperactivity 
disorder (Brown & Landgraf, 2010).  On the other hand, in a study conducted by Grech et al. 
(2015), researchers did not find a significant association between executive functioning and 
attention and stress, depression, anxiety, or quality of life in adults with multiple sclerosis; 
however, poorer performance on tasks of working memory and cognitive flexibility predicted 
higher levels of stress and lower physical quality of life.  Although these studies elucidate the 
possible relationship between executive functioning and HRQoL, more research is needed to 






 The current study used a cross-sectional design to gain information about the relationship 
between executive functioning, glycemic control, and health-related quality of life in youth with 
type 1 diabetes.  Perspectives on executive functioning and HRQoL were gained using both 
parent and self-report measures, while glycemic control was measured using data collected from 
medical records (HbA1c, number of hospitalizations, number of DKA episodes).  Power analysis 
was conducted using the G-power 2 program (2008) before data was collected.  An alpha level of 
.05 and an effect size of .3 for correlational analyses and .15 for regression analysis was used and 
indicated that 162 participants were needed.   
Participants 
Participants were recruited from the Endocrinology practice at Children’s Medical Center 
Dallas (n = 191).  Children ages 12-18, both male and female, with type 1 diabetes, along with 
one caregiver (parent or legal guardian) were included in the study.  Inclusion criteria included 
English-language speakers.  As for exclusion criteria, participants could not have a known 
chromosomal disorder or a developmental delay, as this could impact executive functioning or 
HRQoL and could potentially contribute to an inability to understand self-report materials.  
Finally, youth diagnosed with non-type 1 diabetes (i.e. type 2 diabetes, steroid induced, and so 
on) were excluded, as these diagnoses require different medical interventions and may impact 
executive functioning, health outcomes, and generic and diabetes-specific quality of life.  The 
majority of participants identified as white (60.2%), male (53.4%), and the majority of caregiver 
participants were mothers (74.3%).  The mean age for participants was 14.85.  The study 







Participant demographic characteristics 
 
Variable N % M (SD) 
Age    191  14.85 (1.78) 
Gender    
       Male 102 53.4  
       Female 89 46.6  
Race    
       White 115 60.2  
       African American 36 18.8  
       Hispanic 22 11.5  
       Asian or Pacific Islander 4 2.1  
       Native American 1 .5  
       Other 13 6.8  
Person Reporting    
       Mother/Step-mother 142 74.3  
       Father/Step-father 24 12.6  
       Grandparent 9 4.7  
       Other 10 5.2  






 IRB approval was obtained from Texas A&M University, University of Texas 
Southwestern Medical Center, and by Children’s Medical Center (CMC), Dallas.  Eligible 
participants were identified through a search of EPIC (Children's Medical Center Dallas’s 
electronic medical records database) by the medical provider or research staff.  Recruitment took 





explained to potential participants and if they were interested, information on what is involved 
was provided, with an emphasis on the voluntariness of participation.  Participants were given a 
consent form to review and an opportunity to ask questions; they had as much time as they liked 
to review the form.  Written consent was obtained from the parent or legal guardian and written 
assent was given by the adolescents.   
Participation entailed completion of the questionnaires on quality of life, executive 
functioning, and demographic information.  Questionnaires were completed on an iPad using 
RedCap.  Research staff were available to assist in the completion of forms as needed.  In 
addition, information on medical history and glycemic control (HbA1c) was obtained from 
medical records.  Medical data was collected and recorded by medical staff at the Endocrinology 
clinic and transferred to the subject’s medical chart review on RedCap.  The parent and the 
child/adolescent completed research protocols in the following order: PedsQL™ 4.0 Generic 
Core Scales, PedsQL™ Family Information Form, and the Comprehensive Executive Function 
Inventory (CEFI: Naglieri & Goldstein, 2013).   
The parent and child completed the questionnaires independently from one another and 
were discouraged from consulting one another during the completion of the questionnaires.  If 
the child or parent had a question about an item, the item was not interpreted for them but was 
repeated verbatim.  The subject was prompted to answer the item according to what they thought 
the question meant.  If they still had difficulty selecting an answer, they were asked to choose the 
response that most closely reflected how they felt.  If a parent/child asked for an interpretation or 
score from the responses, they were informed that this was not possible and that their answers 
would be combined with other participants’ answers and analyzed as a group, rather than as 





to ensure that they were answered and that there was not more than one response to the item.  
When the forms were completed, research staff saved the responses to RedCap.  All research 
protocols were de-identified and assigned an identification number, with the corresponding 
parent and child forms assigned a matching identification number.  After completion of 
protocols, participants were given a $10 gift card to Target, which was provided by the 
Endocrinology department at CMC Dallas, and copies of signed consent forms. 
Measures 
Medical Chart Review Form 
At each appointment, the attending research staff completed the medical chart review 
form.  The medical chart review includes the patient’s sociodemographic information, medical 
history, current prescribed medications, age of diagnosis, number of hypo- and hyperglycemic 
episodes over the last six months, number of hospitalizations related to diabetes, history of DKA, 
any comorbid diagnoses, and current measure of HbA1c.  This measure was developed by Dr. 
James Varni. A copy is provided in the Appendix. 
PedsQL™ Family Information Form 
The PedsQL™ Family Information Form assesses demographic information such as the 
date of birth, gender, race/ethnicity, and parental educational and occupational information.  This 
information will be used to gather demographic data about participants. 
 PedsQL™ 4.0 Generic Core Scales 
The PedsQL™ 4.0 Generic Core Scales (Varni, 1998) is 23-item measure of generic 
HRQoL that assesses physical, emotional, social, and school functioning in youth that are 
healthy and chronically ill (Varni & Limbers, 2009).  Self-report forms can be used with youth 





report the frequency of problems over the past month using a five-point Likert scale.  Higher 
scores indicate fewer reported problems.  The PedsQL™ 4.0 generates a Total Scale Score, a 
Physical Health Summary Score, and a Psychosocial Health Summary Score.  Additionally, four 
subscales are produced (Physical Functioning, Emotional Functioning, Social Functioning, and 
School Functioning).  The PedsQL™ 4.0 Generic Core Scales have been studied internationally 
and have acceptable rates of validity and reliability (Hilliard et al., 2013; Varni et al., 2003).  The 
measure has strong internal consistency on both the child and parent reports.  Internal 
consistency ranges from .71 to .88 across scales on the child self-report and from .73 to .89 
across scales on the parent proxy-report (Varni et al., 2003).  Interrater reliability between parent 
and youth reports were moderate (ICC = .60) for the Total Scale Score (Varni, Limbers, & 
Burwinkle, 2007).  Moreover, studies have shown that the PedsQL™ 4.0 Generic Core Scales 
has excellent construct validity, with healthy children reporting significantly less symptoms 
related to poor health-related quality of life compared to chronically ill children (Varni, Seid, & 
Kurtin, 2001; Varni, Burwinkle, Seid, & Skarr, 2003).  In this study, the variables generated by 
the PedsQL™ 4.0 Generic Core Scales of interest included the Total Scale Score, Physical 
Health Summary Score, and the Psychosocial Health Summary Score.  The internal consistency 
of the PedsQL subscales and the Total Scale Score for the dataset were calculated.  Both the self-
report PedsQL (α = .94) and parent-report PedsQL (α = .91) had high internal consistency, 
indicating the subscales and total score on the PedsQL consistently measure the same construct. 
Based on Varni et al. (2003), the cut-off scores for children with chronic health 
conditions were as follows; self-report Total Score (69.7, SD = 13.16), self-report Physical 
Health Summary Score (72.98, SD = 13.88), self-report Psychosocial Health Summary Score 





Summary Score (63.28, SD = 19.98), and parent-report Psychosocial Health Summary Score 
(64.38, SD = 15.84). 
Comprehensive Executive Function Inventory  
The Comprehensive Executive Function Inventory (CEFI; Naglieri & Goldstein, 2013) 
measures parent, teacher, and self-report of executive functioning abilities in children and 
adolescents.  Parent and Teacher report forms assesses youth ranging in age from 5 to 18, while 
the Self-Report form assesses ages 12 to 18 years old.  Each form has 100 questions and uses a 
6-point Likert format to determine behavioral frequency.  The CEFI produces one Full Scale 
Score and nine subscales.  Obtained scores are compared to a nationally normed sample that was 
consistent with the 2009 United States census (Naglieri & Goldstein, 2013).  Subscales include 
Attention, Emotion Regulation, Flexibility, Inhibitory Control, Initiation, Organization, 
Planning, Self-Monitoring, and Working Memory.  All forms of the CEFI have strong internal 
consistency on the Full-Scale score (range = .97 to .99) and interrater reliability was strong 
between parent raters (corrected r = .88) and between teachers (corrected r = .68).  After 
reporters were administered the CEFI seven to thirty days apart, test-retest reliability coefficients 
were found to be high (corrected r = .77 to .91) for the Full-Scale score across forms (Naglieri & 
Goldstein, 2013).  In this study, the variables generated by the CEFI that will be examined 
include the Full-Scale score, Attention, Planning, Self-Monitoring, Inhibitory Control, Emotion 
Regulation, Flexibility and Working Memory subscales. 
The internal consistency of the CEFI subscales and the Full-Scale Score for the dataset 
were calculated.  Both the self-report CEFI (α = .96) and parent-report CEFI (α = .98) had high 





the same construct. A summary of the measures used and the corresponding constructs are 
presented in Table 3. 
 
Table 3 
Variables and measures in current study 
Construct Measure/Variables 
Demographics Medical Chart Review Form; PedsQL™ Family Information Form 
Diagnostic History Medical Chart Review Form 
HRQoL PedsQL™ 4.0 Generic Core Scales: Total Scale Score, Physical 
Health Summary Score, and Psychosocial Health Summary Score 
(Parent and Self Report) 
Glycemic Control Most recent HbA1c, Number of Hypo- and Hyperglycemic 
episodes, number of DKA episodes, History of Ketones, History of 
Diabetes-Related Seizures, and Number of Hospitalizations for 
Diabetes (Medical Chart Review Form) 






















Initial Data Processing 
Initial activity included identifying those protocols that were valid and could be included.  
Scores that were flagged as “invalid” were not included in the analyses, while scores flagged 
with “caution” were further examined.  Scores that were flagged for “caution” based on great 
response variability were not included in data analyses, while those flagged due to a tendency to 
be overly negative or positive were included, as these scores may still reflect true behavior or 
emotions.   
Missing data were examined for frequency and response patterns.  Of the 191 
participants, 178 (93%) of the participants had all the necessary data; six participants (3%) did 
not have the parent-report CEFI, but did have the number of DKA episodes; and five participants 
(3%) did not have any parent-reported measures, but did have the number of DKA episodes.  The 
remaining response patterns had a frequency of 1% or less.   
Seven of the participants were 18-year-olds and did not have a parent or guardian present 
at the medical appointment; this explains some of the missing parent-report data.  The high 
number of missing data for number of DKA episodes since type 1 diabetes diagnosis (11 
participants) was likely in part due to the researcher being unable to find this information in the 
medical chart.  Parent or patient-reported number of DKA episodes since diagnosis was merged 
with the number of DKA episodes in the medical record, with discrepancies favoring the medical 
record.  A consideration for the frequency of missing CEFI data is the length of the CEFI (100 
questions).  Many participants reported frustration with the long length of this questionnaire and 





The missing data were tested for missing completely at random (MCAR) using Little’s 
test (Little, 1988).  Results indicated the data were not MCAR and was statistically significant at 
.01 (p < .05).  Missing at random (MAR) analyses also were conducted to examine the data.  T-
tests showed that missing cases were not significantly different than complete cases, indicating 
that the data are MAR.    
Data were tested for normality by examining the skewness and kurtosis of the data 
distribution.  All variables had a skewness with an absolute value of three or less and kurtosis 
with an absolute value of seven or less, meeting the normality assumptions for structural 
equation modeling (West, Finch, & Curran, 1995), except for medical variables.  Data 
imputation led to greater skewness and kurtosis for HbA1c, number of hospitalizations since 
diagnosis, number of hospitalizations in the past six months, and number of DKA episodes.  
Medical variables no longer met assumptions of normality after imputation, most likely because 
these variables do not come from a normative sample.  As a result, analyses involving HbA1c, 
number of DKA episodes, hospitalizations since diagnosis, and hospitalizations in the past six 
months were conducted with the available data.  Since normality assumptions were not violated 
after mean imputation for executive functioning and quality of life variables, mean imputation 
was used for analyses.  
Using the Shapiro-Wilk test of normality, continuous variables that were not normally 
distributed included HbA1c (p =.95, α < .001) number of DKA episodes (p = .60, α < .001), 
number of times the child was hospitalized in the past 6 months (p = .60, α < .001 ), number of 
times the child has ever been hospitalized (p = .81, α < .001), self-report Physical Health 
Summary Score (p = .89, α < .001) self-report Psychosocial Health Summary Score (p = .94, α < 





Score (p = .83, α < .001), parent-report Psychosocial Health Summary Score (p = .94, α < .001), 
and the parent-report Total Scale Score (p = .93, α < .001), self-report Initiate on the CEFI (p = 
.01, α < .001), self-report Inhibitory Control (p = .95, α < .001), self-report Organization on the 
CEFI (p = .93, α < .001), self-report Emotion Regulation on the CEFI (p = .98, α = .03), self-
report Flexibility on the CEFI (p = .98, α = .002), parent report Emotion Regulation on the CEFI 
(p = .98, α = .01), parent-report Flexibility on the CEFI (p = .98, α = .01), parent-report Initiate 
on the CEFI (p = .98, α = .02), parent-report Organization on the CEFI (p = .98, α = 02), parent 
report Planning on the CEFI (p = .98, α = .02), parent report Self-Monitoring on the CEFI (p = 
.98, α = .02), and parent report Working Memory on the CEFI (p = .98, α = .01).  As a result, 
Spearman’s rho was used to run correlational analyses and the Satorra-Bentler scaled difference 
chi-square test was used to account for non-normal data in SEM (Bryant & Satorra, 2012).   
Descriptive Data for Sample 
 The means and standard deviations were calculated for self- and parent-report scales on 
the CEFI and PedsQL, as well as for health variables.  Mean HbA1c was 9.10 (SD = 2.08), mean 
number of DKA episodes was 1.33 (SD = 2.18), mean number of hospitalizations in the past 6 
months was .47 (SD = .88), and mean number of hospitalizations since diagnosis was 1.17 (SD = 
1.29). The data is presented in Table 4. 
 
Table 4 
Means and standard deviations for glycemic control variables 
Variable Mean SD 
HbA1c 9.10 2.08 





Table 4 continued   
Variable Mean SD 
Hospitalizations Ever 1.17 1.29 
Hospitalizations last 6 months .47 .88 
Notes. HbA1c = glycated hemoglobin; DKA = diabetic ketoacidosis; SD = standard deviation  
 
 
For CEFI scales, the means and standard deviations are presented in Table 5.  Overall, 
this sample had CEFI means comparable to the normative sample of a mean of 100 and a 
standard deviation of 15, with means in the average range. 
 
Table 5 
Means and standard deviations for self and parent-report CEFI 
Subscale/Scale Mean SD 
SR Initiate 99.37 15.09 
SR Organization 96.05 15.98 
SR Planning 100.15 15.05 
SR Self-Monitoring 100.6 15.08 
SR Attention 98.60 15.32 
SR Emotion-Regulation 99.39 16.26 
SR Flexibility 102.70 16.46 
SR Inhibitory Control 101.49 17.04 





Table 5 continued   
Subscale/Scale Mean SD 
SR Full-Scale Score 99.87 14.66 
PR Initiate 97.64 12.90 
PR Organization 96.98 13.20 
PR Planning 97.76 13.64 
PR Self-Monitoring 97.90 13.81 
PR Attention 97.68 13.82 
PR Emotion Regulation 97.63 13.80 
PR Flexibility 99.43 14.41 
PR Inhibitory Control 99.51 14.08 
PR Working Memory 97.52 13.54 
PR Full-Scale Score 97.71 13.30 
Notes. CEFI = Comprehensive Executive Function Inventory; SR = self-report; PR = parent-
report; SD = standard deviation 
 
 
 The means and standard deviations for the self- and parent-report Total Score, Physical 
Health Summary Score, and Psychosocial Health Summary Score on the PedsQL also were 
calculated.  Cut-off scores for significant impairment are 69.7 for self-report Total, 72.98 for 
self-report Physical Health Summary, 66.03 for self-report Psychosocial Health Summary, 65.4 
for parent-report Total Score, 63.28 for parent-report Physical Health Summary, and 64.35 for 
parent-report Psychosocial Health Summary (Varni et al., 2003).  Compared to the cut-off scores 









Means and standard deviations for self- and parent-report PedsQL 
Subscale/Scale Mean SD 
SR Physical Health Summary 89.95 12.17 
SR Psychosocial Health Summary 79.60 13.25 
SR Total Score 82.21 12.14 
PR Physical Health Summary 86.74 15.09 
PR Psychosocial Health Summary 81.49 14.89 
PR Total Score 83.33 13.46 





Confirmatory Factor Analysis of Glycemic Control 
A Confirmatory Factor Analysis (CFA) was conducted on the latent construct of 
glycemic control, as measured by the observed variables of Hba1c, hospitalization for diabetes in 
the past six months, hospitalizations since diagnosis, and number of DKA episodes (n = 178).  
History of seizures and a history of hypoglycemia were removed from the model because of low 
frequency.  A history of ketones was removed from the model due to insignificant factor loading.  
The CFA showed that the model was a good fit for the data (Figure 2).  Using the Satorra-
Bentler scaled adjustment, the model chi-square was not significant, χ²(2) = 0.82 (p = .66), while 





indicating the model is a good fit.  The factor loadings range from .45 (p < .001) for HbA1c to 
.74 (p < .001) for hospitalizations since diagnosis.  Effect sizes ranged from small (R2 = .20) for 
HbA1c to medium (R2 = .55) for number of hospitalizations since diagnosis.  Overall, the model 
explains 74% of the variance of the latent variable of glycemic control (Table 7). 
 




Notes. DKA = diabetic ketoacidosis; HbA1c = glycated hemoglobin; mths. = months 
 
Table 7 
Standardized coefficient, standard error, significance level, and effect sizes for CFA model of 
latent construct of glycemic control 
 
Variable β SE P R2 
HbA1c .45 .09 <.001 .20 
Number of DKA episodes  .58 .08 <.001 .34 





Table 7 continued     
Variable β SE P R2 
Hospitalizations in past 6 mths. .69 .08 <.001 .47 
Error of HbA1c .80 .08 -- -- 
Error of Hospitalizations ever .45 .10 -- -- 
Error of Hospitalizations 6 mths. .53 .11 -- -- 
Error of Number of DKA Episodes .66 .10 -- -- 
Notes. HbA1c = glycated hemoglobin; DKA = diabetic ketoacidosis; CFA = confirmatory factor 




Research Question 1.  Age and glycemic control 
 
Does current age predict glycemic control?  Based on previous research, it was 
hypothesized older age would predict worse glycemic control (i.e., higher HbA1c, more 
hospitalizations, and more episodes of DKA) due to the increased responsibility for diabetes 
management in adolescence.  First, the correlation between age and glycemic control was 
analyzed to see if there was an association using Spearman’s rho.  There were no significant 
correlations between age and HbA1c, hospitalizations in the last 6 months, the number of 












Correlation (rs) between current age and glycemic control  
 
       Age 
Variable rs p 
HbA1c -.02 .39 
Number of DKA Episodes .12 .06 
Hospitalizations last 6 months -.01 .43 
Hospitalizations Ever .07 .18 
Notes. HbA1c = glycated hemoglobin; DKA= diabetic ketoacidosis; * p < .05, ** p < .01 (1-




SEM was conducted to examine if age predicts glycemic control.  Findings showed that 
the model was a good fit for the data.  The model chi-square with Satorra-Bentler adjustment 
was not significant, χ²(5) = 4.33 (p = .50), while the TLI and CFI were 1.02 and 1.00, 
respectively and the RMSEA was .00, indicating good model fit.  Age did not significantly 

























Standardized coefficient, standard error, significance level, and effect sizes for model of child’s 
age predicting glycemic control 
 
Variable β SE p R2 
Child’s age → Glycemic Control .01 .08 .93 .00 
HbA1c .45 .09 <.001 .20 
Hospitalization in past 6 mths. .69 .08 <.001 .47 
Number of Hospitalizations Ever .74 .06 <.001       .55 
Number of DKA Episodes .58 .09 <.001 .34 
Error of Glycemic Control 1.00 .01 -- -- 
Error of HbA1c .80 .08 -- -- 





Table 9 continued     
Variable β SE p R2 
Error of Hospitalizations ever .45 .09 -- -- 
Error of Number of DKA Episodes .66 .10 -- -- 




Research Question 2.  Age and executive functioning 
 
Does age correlate with executive functioning? Research indicates executive functioning 
improves with age.  It was hypothesized age would be associated with executive functioning, 
with older age correlating with higher CEFI scores.  Since the CEFI scores are age-corrected, the 
association between age and executive functioning could not be directly examined.  As a result, 
age was added as a covariate to the relationship between sex and executive functioning.  A 
MANCOVA was performed to examine age, sex, and self- and parent-report executive 
functioning.  Results are presented in Research Question 4. 
Research Question 3.  Sex and glycemic control 
 
Using MANOVA, the association between glycemic control and child’s sex were 
examined.  Levene’s test of equality of equal variances was performed to measure 
homoscedasticity.  Number of DKA episodes (p = .01) and hospitalizations in the past 6 months 
(p = .01) were significant at p < .05, indicating they did not meet the assumption of equal 
variances.  Therefore, the results of the MANOVA for DKA episodes and hospitalizations in the 
past 6 months are not valid.  On the other hand, there was a small but significant association 





gender associated with more hospitalizations since diagnosis.  Results indicated no significant 
relationship between sex and HbA1c (Table 10).  
 
Table 10 
MANOVA (ƞ2) between child’s sex and glycemic control  
 
   Child’s Sex  
Variable ƞ  ƞ2 F p 
HbA1c .11 .01 1.05 .35 
# of DKA Episodes .14 .02 1.68 .19 
Hosp. last 6 mths. .17 .03 2.70 .07 
Hospitalizations Ever .18 .03 3.29 .04* 
Notes. HbA1c = glycated hemoglobin; DKA = diabetic ketoacidosis; Hosp. = hospitalizations; 
mths. = months; dx = diagnosis; * p < .05, ** p < .01; DKA episodes (n = 178); all other 
variables (n = 191)  
 
 
CFA was conducted to examine if sex predicts glycemic control.  The model chi-square 
with the Satorra-Bentler scaled test was not significant, χ²(5) = 4.09 (p = .54).  The TLI and CFI 
were 1.02 and 1.00, respectively.  The RMSEA was .03, which indicates a good model fit.  The 
factor loadings range from .45 (p < .001) for the HbA1c variable to .75 (p < .001) for the number 
of hospitalizations since diagnosis.  Sex was not a significant predictor of glycemic control 





















Standardized coefficient, standard error, significance level, and effect sizes for model of child’s 
sex predicting glycemic control 
 
Variable β SE p R2 
Sex → Glycemic Control -.08 .09 .38 00 
HbA1c .45 .09 <.001 .20 
Hospitalization in past 6 mths. .68 .08 <.001 .46 
Hospitalizations Ever .75 .06 <.001       .56 
DKA Episodes  .59 .08 <.001 .34 
Error of Glycemic Control        .99 .02 -- -- 





Table 11 continued     
Variable β SE p R2 
Error of Hospitalizations 6 mths. .54 .11 -- -- 
Error of Hospitalizations Ever .44 .09 -- -- 
Error of DKA Episodes  .66 .10 -- -- 




Research Question 4.   Sex and executive functioning 
 
 The relation between sex and executive functioning scales on the CEFI were examined 
using MANCOVA, with child’s age added as a covariate.  Levene’s test of equality of equal 
variances was performed to measure homoscedasticity.  Self-report Attention (p = .01), 
Flexibility (p = .02), Initiate (p = .01), Organization (p = .01), and Self-Monitoring (p = .01) 
were significant at p < .05, indicating they did not meet the assumption of equal variances.  
Child’s sex and age were associated with self-report Inhibitory Control, Organization, Planning, 
and Self-Monitoring, but due to not meeting the standard of homogeneity of variance, only the 
variable of Inhibitory Control is valid (Table 12).  As such, child’s sex and age explains some of 
the self-reported inhibition; however, these effects are small. 
 
Table 12  
MANCOVA (ƞp
2) between child’s sex and self-report CEFI scales with child’s age as a covariate  
 
                          Child’s Sex 
Variable ƞp
2   
                            F                          p 





Table 12 continued  
                          Child’s Sex 
Variable ƞp
2   
                            F                          p 
Self-Report Planning .00                   .84                   .36 
Self-Report Organization .11                  22.57              <.01** 
Self-Report Self-Monitoring .04                  7.15                  .01** 
Self-Report Attention .01                  2.11                  .15 
Self-Report Emotion Regulation .01                  1.76                  .19 
Self-Report Flexibility .00                   .83                   .36 
Self-Report Inhibitory Control .13                  26.82               <.01** 
Self-Report Working Memory .00                  38.59               .66 
Self-Report Full Scale Score .01                  2.01                 .16 




Levene’s test of equality of equal variances was performed to measure homoscedasticity 
of parent-report scales on the CEFI.  Parent-report Planning (p = .02), Self-Monitoring (p = .01), 
and Full-Scale score (p = .02) were significant at p < .05, indicating they did not meet the 
assumption of equal variances.  There were no significant differences between child’s sex for 











2) between child’s sex and parent-reported CEFI scales with child’s age as a 
covariate 
 
                            Child’s Sex 
Variable  ƞp
2
                            F                           p 
Parent-Report Initiate .00                   .33                   .57 
Parent-Report Organization .00                   .50                   .48 
Parent-Report Planning .01                  1.16                  .28 
Parent-Report Self-Monitoring .00                   .01                   .93 
Parent-Report Attention .00                   .42                    .52 
Parent-Report Emotion Regulation .01                  1.25                   .26 
Parent-Report Flexibility .00                   .15                    .70 
Parent-Report Inhibitory Control .01                  1.68                   .20 
Parent-Report Working Memory .00                    .03                   .87 
Parent-Report Full Scale Score .00                    .28                   .80 
Notes. CEFI = Comprehensive Executive Function Inventory; * p < .05, ** p < .01; n = 191 
 
A path analysis was conducted to examine if sex predicted executive functioning (Figure 
5).  Results from the path analysis showed that sex did not significantly predict executive 
functioning, as reported by the child, β(191) = .07 (p = .13), or the parent report, β(191) = .09 (p 



















Standardized coefficient, standard error, significance level, and effect sizes for model of child’s 
sex predicting parent and self-report Full Scale score on the CEFI 
 
Variable β SE p R2 
Sex →SR Full Scale score .07 .05 .13 .00 
Sex →PR Full Scale score .09 .07 .20 .00 
Error of SR Full Scale .99 .01 -- -- 
Error of PR Full Scale .99 .01 -- -- 
Notes. CEFI = Comprehensive Executive Function Inventory; SR = self-report; PR = parent-




Research Question 5.  Executive function and glycemic control 
 
Does executive functioning correlate with glycemic control?  It was hypothesized that 
deficits in executive functioning (Full-Scale score from the CEFI) would correlate with poorer 
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glycemic control (higher HbA1c levels) based on previous research.  To test these hypotheses, a 
correlation matrix was computed for the CEFI total and subscales and HbA1c for both parent and 
child ratings using a Spearman’s rho one-tailed test (n = 190).  Results indicated a significant, 
but small, negative relationship between HbA1c and self-report Organization, Self-Monitoring, 
Attention, Emotion Regulation, Inhibitory Control, and the Full-Scale score (see Table 15).  In 
effect as HbA1c levels went down (better glycemic control), executive functioning went up. 
Table 15 
Correlations (rs) between HbA1c and self-reported CEFI scales 
HbA1c 
Variable     rs p 
Self-reported Initiate -.09 .11 
Self-reported Organization -.18** .01 
Self-reported Planning -.12 .06 
Self-reported Self-Monitoring -.16**  .01 
Self-reported Attention -.15*   .02 
Self-reported Emotion Regulation -.21** <.01 
Self-reported Flexibility  -.07    .16 
Self-reported Inhibitory Control -.17**    .01 
Self-reported Working Memory -.07  .17 
Self-reported Full-Scale score -.17** .01 
Notes. HbA1c = glycated hemoglobin; CEFI = Comprehensive Executive Function Inventory; *p 
< .05, ** p < .01 (1-tailed); n = 190 
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Additionally, self-report CEFI scales were examined with number of hospitalizations in 
the past six months, number of hospitalizations since diagnosis, and number of DKA episodes.  
There were no significant correlations between number of DKA episodes and self-report 
executive functioning, as measured by the CEFI (Table 16). 
Table 16 
Correlations (rs) between number of DKA episodes and self-reported CEFI scales 
     Number of DKA episodes 
    rs p 
Self-reported Initiate  .04   .31 
Self-reported Organization -.06    .20 
Self-reported Planning -.02  .42 
Self-reported Self-Monitoring  .02   .38 
Self-reported Attention  .02      .40 
Self-reported Emotion Regulation -.07   .19 
Self-reported Flexibility  -.01     .48 
Self-reported Inhibitory Control -.02     .41 
Self-reported Working Memory -.06 .23 
Self-reported Full-Scale score -.01 .45 
Notes. DKA = diabetic ketoacidosis; CEFI = Comprehensive Executive Function Inventory; * p 
< .05, ** p < .01 (1-tailed); n = 180 
62 
There were significant negative correlations between the number of hospitalizations since 
diagnosis and self-report Inhibitory Control and Organization (Table 17).  As number of 
hospitalizations since diagnosis increased, organizational skills and inhibition decreased. 
Table 17 
Correlations (rs) between number of hospitalizations since diagnosis and self-reported CEFI 
scores.  
Number of hospitalizations since diagnosis 
    rs p 
Self-reported Initiate  -.08  .12 
Self-reported Organization  -.12*   .05 
Self-reported Planning  -.06 .22 
Self-reported Self-Monitoring  -.07 .17 
Self-reported Attention  -.07     .16 
Self-reported Emotion Regulation  -.11 .07 
Self-reported Flexibility    .00  .50 
Self-reported Inhibitory Control  -.12*   .05 
Self-reported Working Memory  -.07 .16 
Self-reported Full-Scale score  -.07 .16 
Notes. CEFI = Comprehensive Executive Function Inventory; * p < .05, ** p < .01 (1-tailed); n = 
190 
63 
The number of hospitalizations in the past 6 months was not significantly correlated with 
any self-report CEFI scales (Table 18).  
Table 18 
Correlations (rs) between number of hospitalizations in the past 6 months and self-reported CEFI 
scores 
 Number of hospitalizations in past 6 mths. 
    rs p 
Self-reported Initiate  .02        .40 
Self-reported Organization  -.11     .07 
Self-reported Planning  -.02 .37 
Self-reported Self-Monitoring   .01 .43 
Self-reported Attention  -.04   .29 
Self-reported Emotion Regulation  -.02 .40 
Self-reported Flexibility    .01    .44 
Self-reported Inhibitory Control   .00 .50 
Self-reported Working Memory  -.06 .20 
Self-reported Full-Scale score   .01     .45 
Notes. CEFI = Comprehensive Executive Function Inventory; mths = months; * p < .05, ** p < 
.01 (1-tailed); n = 190 
The relationship between parent-report on the CEFI and HbA1c also was analyzed using 
Spearman’s rho.  There was a significant, but small, negative correlation between HbA1c and all 
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parent-reported scales on the CEFI (Table 19). As with self-report, the higher the HbA1c (poorer 
glycemic control), the lower the executive functioning domain. 
Table 19 
Correlations (rs) between HbA1c and parent-reported CEFI scales 
HbA1c 
    rs p 
Parent-reported Initiate -.18** .01 
Parent-reported Organization  -.15*   .02 
Parent-reported Planning -.22**          .00 
Parent-reported Self-Monitoring -.15* .02 
Parent-reported Attention       -.17* .01 
Parent-reported Emotion Regulation -.25** <.01 
Parent-reported Flexibility -.12*  .05 
Parent-reported Inhibitory Control -.19**  <.01 
Parent-reported Working Memory -.16* .01 
Parent-reported Full-Scale score -.19**   .01 
Notes. HbA1c = glycated hemoglobin; CEFI = Comprehensive Executive Function Inventory; * 
p < .05, ** p < .01 (1-tailed); n = 190 
Parent-reported CEFI scales also were examined in relation to number of hospitalizations 
in the past 6 months, the number of hospitalizations since diagnosis, and the number of DKA 





all parent-reported CEFI scales (n = 180; Table 20).  As number of DKA episodes increased, 






Correlations (rs) between number of DKA episodes and parent-reported CEFI scales 
 
      Number of DKA episodes 
     rs                                                     p 
Parent-reported Initiate -.20*                                <.01 
Parent-reported Organization -.15*                                  .02 
Parent-reported Planning -.21**                              <.01 
Parent-reported Self-Monitoring -.23**                               <.01 
Parent-reported Attention  -.22**                               <.01 
Parent-reported Emotion Regulation  -.28**                               <.01 
Parent-reported Flexibility                                    -.24**                               <.01 
Parent-reported Inhibitory Control -.21**                                <.01 
Parent-reported Working Memory -.19**                                  .01 
Parent-reported Full-Scale score -.22**                                 <.01  
Notes. DKA = diabetic ketoacidosis; CEFI = Comprehensive Executive Function Inventory; * p 




Number of hospitalizations in the past 6 months had small significant negative 





(Table 21).  As the number of hospitalizations in the past 6 months increased, parent-reported 
executive functioning decreased. 
 
Table 21 
Correlations (rs) between parent-reported CEFI scores and number of hospitalizations in the last 
6 months 
 
   Hospitalizations in the last 6 months 
           rs                                                  p 
Parent-reported Initiate       -.14*                              .03 
Parent-reported Organization       -.12*                              .04 
Parent-reported Planning       -.13*                              .04 
Parent-reported Self-Monitoring       -.09                                .12 
Parent-reported Attention       -.18**                            .01 
Parent-reported Emotion Regulation       -.26**                          <.01 
Parent-reported Flexibility      -.18**                             .01         
Parent-reported Inhibitory Control      -.18**                             .01 
Parent-reported Working Memory      -.15*                               .02 
Parent-reported Full-Scale score      -.17**                             .01 





There were also small significant negative Spearman’s rho correlations between number 





number of hospitalizations since diagnosis increased, parent-reported executive functioning 
decreased.   
 
Table 22 
Correlation (rs) between parent-reported CEFI scales and number of hospitalizations since 
diagnosis 
 
 Number of hospitalizations since diagnosis 
          rs                                                     p 
Parent-reported Initiate      -.18**                              .01 
Parent-reported Organization      -.14*                                .03 
Parent-reported Planning      -.16*                                .02 
Parent-reported Self-Monitoring     -.17*                                 .02 
Parent-reported Attention     -.19**                               .01 
Parent-reported Emotion Regulation     -.25**                             <.01 
Parent-reported Flexibility     -.20**                               .01 
Parent-reported Inhibitory Control     -.18**                               .01  
Parent-reported Working Memory     -.21**                               .01 
Parent-reported Full-Scale score     -.20**                               .01 






Research Question 6.  Executive function and HRQoL 
 
 In order to test the hypothesis that executive functioning predicts HRQoL, a Spearman’s 





variables (n = 191).  For both self-report (Table 23) and parent-report (Table 24) measures, there 
were positive significant correlations between all three HRQoL variables and all the CEFI scales.  






Correlations (rs) between self-report CEFI scales and self-report HRQoL 
 
    Physical  Psychosocial          Total 
  rs                     p   rs                   p        rs                      p  
Self-reported Initiate .34**    <.001 .31**   <.001      .35**      <.001 
Self-reported Organization .34**    <.001 .40**   <.001      .42**      <.001 
Self-reported Planning .30**    <.001 .37**   <.001      .38**      <.001 
Self-reported Self-Monitoring .34**    <.001 .38**   <.001      .40**      <.001 
Self-reported Attention .40**    <.001 .47**   <.001      .49**      <.001 
Self-reported Emotion Regulation .36**    <.001 .47**   <.001      .47**      <.001 
Self-reported Flexibility .30**    <.001 .32**   <.001      .33**      <.001 
Self-reported Inhibitory Control .32**    <.001 .38**   <.001      .38**      <.001 
Self-reported Working Memory .38**    <.001 .50**   <.001      .50**      <.001 
Self-reported Full-Scale score .39**    <.001 .46**   <.001      .48**      <.001 
Notes. CEFI = Comprehensive Executive Function Inventory; HRQoL = health-related quality of 



















Correlations (rs) between parent-reported CEFI scales and parent reported HRQoL 
 
 Physical Psychosocial     Total 
 rs                     p rs                   p          rs                   p  
Parent-reported Initiate .30**    <.001 .37**   <.001       .40**      <.001 
Parent-reported Organization .24**    <.001 .36**   <.001        .37**     <.001 
Parent-reported Planning .23**    <.001 .38**   <.001        .38**     <.001 
Parent-reported Self-Monitoring .24**    <.001 .38**   <.001        .38**     <.001 
Parent-reported Attention .30**    <.001 .42**   <.001        .43**     <.001 
Parent-reported Emotion Reg. .26**   <.001 .40**   <.001        .40**     <.001 
Parent-reported Flexibility .21**   <.001 .32**   <.001        .34**      <.001 
Parent-reported Inhibitory Control .20**   <.001 .36**   <.001        .34**      <.001 
Parent-reported Working Memory .26**   <.001 .42**   <.001        .41**      <.001 
Parent-reported Full-Scale score .27**   <.001 .42**   <.001        .43**      <.001 
Notes. CEFI = Comprehensive Executive Function Inventory; HRQoL = health-related quality of 




SEM analysis was conducted to examine if executive functioning, as measured by the 
Full-Scale scores for child and parent-report CEFIs, predicted HRQoL, as measured by the Total 
Scale Scores on the parent and self-report PedsQL (Figure 6).  The model chi-square using the 
Satorra-Bentler adjustment was significant, χ²(1) = 14.18, p <.01, indicating the model is not a 
good fit for the data.  The TLI and CFI were .89 and .39, indicating poor model fit, while the 
RMSEA was .26. 
In the model, executive functioning significantly predicted HRQoL, β(191) = .78, p <.001 
and had an effect size of R2 = .61 (Table 25).  Factor loadings for executive functioning ranged 





CEFI Full Scale score.  Factor loading for HRQoL ranged from .56 (p < .001) for parent-report 
Total Scale Sore on the PedsQL to .80 (p < .001) for the self-report Total Scale Score on the 
PedsQL.  Although this model accounted for 77% of the overall variance, based on the fit 




Figure 6. Model of executive functioning predicting HRQoL Total Scale Scores on the PedsQL 


















Standardized coefficient, standard error, significance level, and effect sizes for model of 
executive functioning predicting HRQoL  
 
Variable β SE p R2 
Executive Functioning → HRQoL .78 .09 <.001 .61 
SR Full-Scale score (CEFI) .76 .09 <.001 .24 
PR Full-Scale Score (CEFI) .49 .08 <.001 .64 
SR Total Score (PedsQL) .80 .07 <.001       .31 
PR Total Score (PedsQL) .56 .08 <.001       -- 
Error of HRQoL .39 .14 -- -- 
Error of SR Full-Scale .42 .13 -- -- 
Error of PR Full-Scale .76 .08 -- -- 
Error of SR Total Score .36 .11 -- -- 
Error of PR Total Score .69 .07 --  
Notes. HRQoL = health-related quality of life; CEFI = Comprehensive Executive Functioning 





A model examining executive functioning predicting self-report Psychosocial and 
Physical Health Summary Scores on the PedsQL also was conducted (Figure 7).  The model chi-
square was not significant, χ²(1) = 1.51, p = .22.  The TLI and CFI were .99 and 1.00, 
respectively.  The RMSEA was .05, which indicates a good model fit.  Factor loadings for 
executive functioning ranged from .86 (p <.001) for the self-report CEFI Full-Scale score to .44 
(p < .001) for the parent-report CEFI Full-Scale score (Table 26).  Factor loadings for self-report 





for the Physical Health Summary score.  Executive functioning was found to significantly predict 
self-reported HRQoL β(191) = .61 (p < .001) and had a small effect size (R2 = .38).  The model 
accounted for 78% of the overall variance.  Increases in executive functioning predicted 























Standardized coefficient, standard error, significance level, and effect sizes for model of 
executive functioning predicting self-report physical and psychosocial HRQoL  
 
Variable β SE p R2 
Executive Functioning → HRQoL .61 .09  <.001 .37 
SR Full-Scale score (CEFI) .87 .11  <.001 .76 
PR Full-Scale Score (CEFI) .47 .08  <.001 .18 
SR Physical Health Score 
(PedsQL) 
.76 .05  <.001       .57 
SR Psychosocial Health Score 
(PedsQL) 
.94 .05  <.001 .89 
Error of HRQoL .63 .11 -- -- 
Error of SR Full-Scale .24 .19 -- -- 
Error of PR Full-Scale .82 .10 -- -- 
Error of SR Physical Health Score .43 .08 -- -- 
Error of SR Psychosocial Health 
Score 
.11 .10 -- -- 
Notes. CEFI = Comprehensive Executive Function Inventory; PedsQL = Pediatric Quality of 




Additionally, SEM was conducted to examine the hypothesis that executive functioning, 
as measured by the parent and self-report CEFI Full Scale scores, predicts parent-reported 
HRQoL, as measured by the Physical and Psychosocial Health Summary Scores on the PedsQL.  





executive functioning may not be a good predictor of parent-report HRQoL.  Based on the three 
models examining executive functioning and HRQoL, the best fit for the data is executive 
functioning predicting self-report Physical and Psychosocial HRQoL. 
Research Question 7.  HRQoL and glycemic control 
To test the hypothesis that HRQoL and glycemic control are related, two Spearman’s rho 
correlational matrices examining self and parent-reported Psychosocial Health Summary Scores, 
Physical Health Summary Scores, and Total Scale Scores with HbA1c, number of DKA 
episodes, number of hospitalizations in the past 6 months, and number of hospitalizations since 
diagnosis.  Results indicated a small significant negative correlation between HbA1c and self-
reported Psychosocial Health Summary Score and self-report Total Scale Score. Additionally, 
there were small significant negative correlations between HbA1c and all parent-reported 
HRQoL scores (Table 27).  As HRQoL increased, HbA1c decreased (better glycemic control), 





Correlations (rs) between HbA1c and HRQoL  
 
                         HbA1c 
       rs                                                    p 
Self-reported Physical Health    -.08                                .15 
Self-reported Psychosocial Health                            -.14*                              .03 
Self-reported Total Scale Score                          -.14*                              .03 
Parent-reported Physical Health    -.19**                          <.01 
Parent-reported Psychosocial Health    -.22**                          <.01 
75 
Table 27 continued 
HbA1c 
      rs p 
Parent-reported Total Scale Score    -.23** <.01 
Notes. HbA1c = glycated hemoglobin; HRQoL = health-related quality of life; * p < .05, ** p < 
.01 (1-tailed); n = 190 
The number of DKA episodes was significantly correlated with all self- and parent-report 
HRQoL scales on the PedsQL (Table 28).  As number of DKA episodes increased, self and 
parent-reported physical health quality of life decreased. 
Table 28 
Correlations (rs) between number of DKA episodes and HRQoL 
         Number of DKA episodes 
  rs p 
Self-reported Physical Health  -.23**       <.01 
Self-reported Psychosocial Health    -.22**         <.01 
Self-reported Total Scale Score    -.23**       <.01 
Parent-reported Physical Health    -.20**                 <.01 
Parent-reported Psychosocial Health    -.21**    <.01 
Parent-reported Total Scale Score    -.23**  <.01 
Notes. DKA = diabetic ketoacidosis; HRQoL = health-related quality of life; * p < .05, ** p < 





A Spearman’s rho correlation matrix was created to examine the relationship between 
HRQoL scales and number of hospitalizations in the past 6 months.  There was a significant 
negative correlation between number of hospitalizations in the past 6 months and all self- and 
parent-reported HRQoL scales on the PedsQL.  As the number of hospitalizations in the past 6 
months increased, parent and self-reported physical, psychosocial, and overall health-related 
quality of life decreased (Table 29). 
 
Table 29 
Correlation (rs) between number of hospitalizations in the past 6 months and HRQoL  
 
 Number of hospitalizations in past 6 mths. 
           rs                                                      p 
Self-reported Physical Health         -.21**                          <.01 
Self-reported Psychosocial Health         -.19**                          <.01 
Self-reported Total Scale Score         -.21**                          <.01 
Parent-reported Physical Health         -.25**                          <.01 
Parent-reported Psychosocial Health         -.21*                            <.01 
Parent-reported Total Scale Score         -.26**                          <.01 




A Spearman’s rho correlational matrix was completed to examine the relationship 
between HRQoL and number of hospitalizations since diagnosis.  There was a significant 





reported HRQoL scales.  As the number of hospitalizations since diagnosis increased, physical, 
psychosocial, and overall health-related quality of life decreased (Table 30). 
 
Table 30 
Correlations (rs) between number of hospitalizations since diagnosis and HRQoL  
 
 Number of hospitalizations since diagnosis 
           rs                                                  p 
Self-reported Physical Health      -.23**                          <.01 
Self-reported Psychosocial Health      -.23**                          <.01 
Self-reported Total Summary Score      -.24**                          <.01 
Parent-reported Physical Health      -.24**                          <.01 
Parent-reported Psychosocial Health      -.28**                          <.01 
Parent-reported Total Summary Score      -.29**                          <.01 




SEM was conducted to examine the relationship between glycemic control and HRQoL.  
It was hypothesized that these variables would negatively covary with one another.  Results 
indicated the model chi-square was not significant, χ²(8) = 3.31, p = .91.  The TLI and CFI were 
1.07 and 1.00, respectively, while the RMSEA was .00, which indicates the model is a good fit 
for the data.  Glycemic control significantly negatively covaried with HRQoL (β(178) = -.62 (p < 
.001).  As glycemic control worsened, HRQoL also decreased (Figure 8; Table 31).  Overall, the 

















Standardized coefficient, standard error, significance level, and effect sizes for model showing 
the covariance between glycemic control and HRQoL 
 
Variable β SE p R2 
Covariance of GC and HRQoL -.62     .10   <.001 -- 
HbA1c .46 .09             <.001 .21 
Hospitalizations past 6 mths. .66 .08    <.001 .44 
Hospitalizations Ever .75 .05  <.001 .56 
Number of DKA Episodes .60 .09 <.001 .36 
SR Total Score (PedsQL) .58 .09 <.001 .34 






Table 31 continued     
Variable β SE p R2 
Error of HbA1c .79 .08 -- -- 
Error of Hospitalizations past 6 
mths. 
.56 .11 -- -- 
Error of Hospitalizations Ever .44 .08 -- -- 
Error of DKA Episodes .64 .10 -- -- 
Error of SR Total Score .66 .11 -- -- 
Error of PR Total Score .42 .17 -- -- 
Notes. HRQoL = health-related quality of life; PedsQL = Pediatric Quality of Life Inventory; GC 
= glycemic control; HbA1c = glycated hemoglobin; DKA = diabetic ketoacidosis; mths = 




Research Question 8. Testing the model 
 
 To test the hypothesis that the data fits the hypothesized model, SEM of the proposed 
model was conducted (Figure 9).  The model using the Satorra-Bentler chi-square adjustment 
was significant, χ²(17) = 27.43, p = .05.  The TLI and CFI were .92 and .95, respectively, and the 
RMSEA was .06, which indicates adequate model fit for the data.  Executive functioning, β(178) 
= .72 (p <.001) significantly predicted HRQoL, with improvements in executive functioning 
predicting improvements in HRQoL.  Additionally, glycemic control significantly predicted 
HRQoL β(178) = -.35 (p < .01), with worse glycemic control (higher HbA1c, more 
hospitalizations, more DKA episodes) predicting lower HRQoL.  A large portion of the variance 
of HRQoL was explained in the model (R2 = .84), while 96% of the overall variance explained in 





functioning β(178) = -.36 (p < .01).  Worse glycemic control was associated with worse 
executive functioning (Table 32). 
 
Figure 9. Hypothesized model showing the relationship between glycemic control, executive 




            
Notes. DKA = diabetic ketoacidosis; HbA1c = glycated hemoglobin; mths. = months; HRQoL = 





















Standardized coefficient, standard error, significance level, and effect sizes for model showing 
the relationship between glycemic control, executive functioning and HRQoL 
 
Variable β SE p R2 
EF → HRQoL .72     .11   <.001 -- 
GC → HRQoL -.36 .11 <.01 -- 
Covariance of GC and EF -.36 .11 .01 .50 
SR Full Scale score (CEFI) .71 .08   <.001 .28 
PR Full Scale Score (CEFI) .53 .08 <.001 .21 
HbA1c .46 .09    <.001 .44 
Hospitalizations past 6 mths. .66 .08    <.001 .56 
Hospitalizations Ever .76 .05  <.001 .35 
Number of DKA Episodes .59 .09 <.001 .47 
SR Total Score (PedsQL) .69 .06 <.001 .42 
PR Total Score (PedsQL) .65 .08 <.001 -- 
Error of HRQoL .16 .14 -- -- 
Error of HbA1c .79 .08 -- -- 
Error of Hospitalizations past 6 
mths. 
.56 .11 -- -- 
Error of Hospitalizations Ever .44 .08 -- -- 
Error of DKA Episodes .65 .10 -- -- 
Error of SR Full scale  .50 .12 -- -- 





Table 32 continued     
Variable β SE p R2 
Error of PR Full scale .72 .08 -- -- 
Error of SR Total Score .53 .08 -- -- 
Error of PR Total Score .58 .11 --  
Notes. HRQoL = health-related quality of life; CEFI = Comprehensive Executive Function 
Inventory; PedsQL = Pediatric Quality of Life Inventory; mths = months; SR = self-report; PR = 




A second SEM model was conducted to examine if the relationship between variables 
was better explained by covariance, rather than prediction (Figure 10).  Using the Satorra-Bentler 
scaled test adjustment, the model chi-square was significant, χ²(17) = 27.43, p = .05.  The TLI 
and CFI were .92 and .95, respectively, and the RMSEA was .06, which indicates poor to 
adequate model fit for the data.  Executive functioning, β(178) = .85 (p <.001) significantly 
covaried with HRQoL, with higher executive functioning associated with higher HRQoL.  
Executive functioning also significantly covaried with glycemic control β(178) = -.36 (p < .01), 
with poorer glycemic control associated with lower executive functioning.  Finally, glycemic 
control significantly covaried with HRQoL β(178) = -.62 (p < .001), with poorer glycemic 
control associated with lower HRQoL.  Although the model explained 93% of the variance, fit 

















Notes. DKA = diabetic ketoacidosis; HbA1c = glycated hemoglobin; mths. = months; HRQoL = 





Standardized coefficient, standard error, significance level, and effect sizes for the model 
examining the covariance between glycemic control, executive functioning, and HRQoL 
 
Variable β SE p R2 
Covariance of EF and HRQoL .85     .09   <.001 -- 
Covariance of EF and GC -.36 .11 <.01 -- 
Covariance of GC and HRQoL -.62 .10 <.001 -- 
SR Full Scale score (CEFI) .71 .08   <.001 .50 
PR Full Scale Score (CEFI) .53 .08 <.001 .28 
HbA1c .46 .09            <.001 .21 
Hospitalizations past 6 mths. .66 .08    <.001 .44 
Hospitalizations Ever .75 .05  <.001 .56 
Number of DKA Episodes .59 .09 <.001 .35 
SR Total Score (PedsQL) .69 .06 <.001 .47 
PR Total Score (PedsQL) .65 .08 <.001 .42 
Error of HRQoL 1 -- -- -- 
Error of EF 1 -- -- -- 
Error of GC 1 -- -- -- 
Error of HbA1c .79 .08 -- -- 
Error of Hospitalizations past 6 
mths. 
.56 .11 -- -- 
Error of Hospitalizations Ever .44 .08 -- -- 





Table 33 continued     
Variable β SE p R2 
Error of DKA Episodes .65 .10 -- -- 
Error of SR Full scale  .50 .12 -- -- 
Error of PR Full scale .72 .08 -- -- 
Error of SR Total Score .53 .08 -- -- 
Error of PR Total Score .58 .11 -- -- 
Notes. HRQoL = health-related quality of life; CEFI = Comprehensive Executive Function 
Inventory; PedsQL = Pediatric Quality of Life Inventory; EF = executive functioning; GC = 
glycemic control; mths = months; SR = self-report; PR = parent-report; n = 178 
 
Since the model with executive functioning predicting self-report Physical and 
Psychosocial Health Summary scores was found to best fit the data, this model was integrated 
into the hypothesized model (Figure 11).  Using the Satorra-Bentler scaled test adjustment, the 
model chi-square was not significant, χ²(17) = 16.05, p = .52.  The TLI and CFI were 1.01 and 
1.00, while the RMSEA was .00, indicating good model fit.  Executive functioning significantly 
predicted self-reported Physical and Psychosocial quality of life, β(178) = .54 (p <.001), while 
glycemic control significantly predicted HRQoL, β(178) = -.23 (p = .01), with poorer glycemic 
control associated with lower executive functioning.  Finally, glycemic control significantly 
covaried with executive functioning, β(178) = - .27 (p =.01), with poorer glycemic control 






Figure 11. Model showing the relationship between glycemic control, executive functioning, and 
self-report HRQoL.   
Notes. DKA = diabetic ketoacidosis; HbA1c = glycated hemoglobin; mths. = months; HRQoL = 
health-related quality of life; SR = self-report; PR = parent-report 
Table 34 
Standardized coefficient, standard error, significance level, and effect sizes for model showing 
the relationship between glycemic control, executive functioning and self-report HRQoL 
Variable β SE p R2 
EF → HRQoL .54     .09   <.001 -- 
GC → HRQoL -.23 .09 .01 -- 
Covariance of GC and EF -.27 .10 .01 -- 
SR Full Scale score (CEFI) .89 .11   <.001 .79 





Table 34 continued     
Variable β SE p R2 
HbA1c .46 .09    <.001 .21 
Hospitalizations past 6 mths. .68 .08    <.001 .56 
Hospitalizations Ever .75 .06  <.001 .34 
Number of DKA Episodes .58 .09 <.001 .58 
SR Physical (PedsQL) .76 .05 <.001 .91 
SR Psychosocial (PedsQL) .96 .05 <.001 -- 
Error of HRQoL .58 .09 -- -- 
Error of HbA1c .79 .08 -- -- 
Error of Hospitalizations past 6 
mths. 
.54 .11 -- -- 
Error of Hospitalizations Ever .44 .09 -- -- 
Error of DKA Episodes .66 .11 -- -- 
Error of SR Full scale  .21 .20 -- -- 
Error of PR Full scale .82 .07 -- -- 
Error of SR Physical .42 .08 -- -- 
Error of SR Psychosocial .09 .09 --  
Notes. HRQoL = health-related quality of life; CEFI = Comprehensive Executive Function 
Inventory; PedsQL = Pediatric Quality of Life Inventory; EF = executive functioning; GC = 
glycemic control; mths = months; SR = self-report; PR = parent-report; n = 178 
 
 
Additionally, age was added to the model to see if it was a significant predictor of the 





not significant, χ²(24) = 23.61, p = .48.  The TLI and CFI were both .99, while the RMSEA was 
.00, indicating good model fit.  Factor loadings for glycemic control, executive functioning and 
self-report HRQoL remained the same as the model without age.  Child’s age significantly 
predicted self-reported HRQoL, β(178) = - .13 (p =.04), with younger age associated with better 
HRQoL.  On the other hand, the model explained 95% of the variance, so the addition of age in 
the model did not add to what is explained in the variance of the model without age (Table 35). 
 
Figure 12. Model showing the relationship between glycemic control, executive functioning, 
self-report HRQoL, and age.   
 
 
Notes. DKA = diabetic ketoacidosis; HbA1c = glycated hemoglobin; mths. = months; HRQoL = 










Standardized coefficient, standard error, significance level, and effect sizes for model showing 
the relationship between glycemic control, executive functioning, self-report HRQoL, and age 
 
Variable β SE p R2 
EF → HRQoL .56     .09   <.001 -- 
GC → HRQoL -.23 .09 .01 -- 
Age → HRQoL -.13 .06 .04 -- 
Covariance of GC and EF -.27 .10 .01 -- 
SR Full Scale score (CEFI) .89 .11   <.001 .79 
PR Full Scale Score (CEFI) .42 .08 <.001 .18 
HbA1c .46 .09    <.001 .21 
Hospitalizations past 6 mths. .68 .08    <.001 .56 
Hospitalizations Ever .75 .06  <.001 .34 
Number of DKA Episodes .58 .09 <.001 .58 
SR Physical (PedsQL) .77 .05 <.001 .91 
SR Psychosocial (PedsQL) .95 .05 <.001 -- 
Error of HRQoL .55 .09 -- -- 
Error of HbA1c .79 .08 -- -- 
Error of Hospitalizations past 6 
mths. 
.54 .11 -- -- 
Error of Hospitalizations Ever .44 .09 -- -- 
Error of DKA Episodes .66 .11 -- -- 





Table 35 continued     
Variable β SE p R2 
Error of PR Full scale .82 .07 -- -- 
Error of SR Physical .41 .08 -- -- 
Error of SR Psychosocial .10 .09 --  
Notes. HRQoL = health-related quality of life; CEFI = Comprehensive Executive Function 
Inventory; PedsQL = Pediatric Quality of Life Inventory; EF = executive functioning; GC = 
glycemic control; mths = months; SR = self-report; PR = parent-report; n = 178 
 
 
A model examining the covariance of glycemic control, executive functioning, and self-
report Physical and Psychosocial Health Summary scores on the PedsQL was also analyzed 
(Figure 13).  Using the Satorra-Bentler scaled test adjustment, the model chi-square was not 
significant, χ²(17) = 16.05, p = .52.  The TLI and CFI were 1.01 and 1.00, while the RMSEA was 
.00, indicating good model fit.  Executive functioning significantly covaried with self-reported 
Physical and Psychosocial quality of life, β(178) = .61 (p <.001), while glycemic control 
significantly covaried with HRQoL (β(178) = -.38 (p = .01).  Finally, glycemic control 
significantly covaried with executive functioning, β(178) = -.27 (p =.01), with poorer glycemic 
control associated with lower HRQoL.  The model explained 99% of the variance, indicating this 
may be the best model for the data (Table 36).  Age was not examined in this model since it is 















Notes. DKA = diabetic ketoacidosis; HbA1c = glycated hemoglobin; mths. = months; HRQoL = 




Standardized coefficient, standard error, significance level, and effect sizes for the model 
examining the covariance between glycemic control, executive functioning, and self-report 
HRQoL 
 
Variable β SE p R2 
Covariance of EF and HRQoL .61     .08   <.001 -- 
Covariance of GC and HRQoL -.38 .10 <.001 -- 
Covariance of GC and EF -.27 .10 <.01 -- 





Table 36 continued     
Variable β SE p R2 
PR Full Scale Score (CEFI) .42 .08 <.001 .18 
HbA1c .46 .09    <.001 .21 
Hospitalizations past 6 mths. .68 .08    <.001 .46 
Hospitalizations Ever .76 .05  <.001 .56 
Number of DKA Episodes .58 .09 <.001 .34 
SR Physical (PedsQL) .76 .05 <.001 .58 
SR Psychosocial (PedsQL) .96 .05 <.001 .91 
Error of HbA1c .79 .08 -- -- 
Error of Hospitalizations past 6 
mths. 
.54 .11 -- -- 
Error of Hospitalizations Ever .44 .09 -- -- 
Error of DKA Episodes .66 .11 -- -- 
Error of SR Full scale  .21 .20 -- -- 
Error of PR Full scale .82 .07 -- -- 
Error of SR Physical .42 .08 -- -- 
Error of SR Psychosocial .09 .09 -- -- 
Notes. HRQoL = health-related quality of life; CEFI = Comprehensive Executive Function 
Inventory; PedsQL = Pediatric Quality of Life Inventory; EF = executive functioning; GC = 









This study examined the relationship between glycemic control, executive functioning, 
and health-related quality of life in youth with type 1 diabetes.  There is little research that has 
explored the association between executive functioning and HRQoL and this is one of the first 
studies to examine the relationship between these variables in youth with type 1 diabetes.  The 
proposed model hypothesized that executive functioning would predict HRQoL, while glycemic 
control would covary with HRQoL, and glycemic control and executive functioning would also 
covary.  Moreover, age and sex were hypothesized to significantly correlate and predict glycemic 
control and executive functioning.  In the overall model, executive functioning was found to be a 
significant predictor of self-report HRQoL by itself, but the addition of glycemic control was 
necessary for executive functioning to predict parent-report HRQoL.  These findings are 
consistent with past research that found a significant association between executive functioning 
and HRQoL in other medical conditions (de Vries & Geurts, 2015; Grech et al., 2015; Laffond et 
al., 2011; Krpan et al., 2007).  Furthermore, in a study by Jaser et al. (2012), self-management 
mediated coping and quality of life in youth with type 1 diabetes.  
On the other hand, based on the model examining the covariance between executive 
functioning, HRQoL, and glycemic control, the relationship between executive functioning and 
self-reported HRQoL may be better explained by covariance, rather than prediction.  Executive 
functioning and self-reported HRQoL significantly covaried with one another, such that as 
executive functioning increased, HRQoL also increased.  In the model where all variables 
covaried, 99% of the variance was explained, compared to the 95% of the variance explained in 





research is needed to elucidate the exact mechanisms of this relationship and future studies 
should focus on further exploratory model analyses. 
In line with the hypothesized model, glycemic control significantly covaried with parent- 
and self-reported HRQoL.  As glycemic control became poorer (increased HbA1c, more 
hospitalizations, more DKA episodes), self-report HRQoL decreased.  Consistent with past 
research demonstrating a significant association between glycemic instability and physical and 
psychosocial quality of life (Jacobson et al., 2013; Lawes et al., 2014; Lawerence et al., 2012; 
Viklund & Ortqvist, 2014), as well as diabetes-specific quality of life (DQoL; Ingerski et al., 
2010).  In another SEM model, glycemic control significantly predicted self-report HRQoL.  
Currently, there has been little research that has explored if HRQoL and glycemic control 
significantly predict one another.  One study did find lower DQoL to be a significant predictor of 
worse glycemic control over time (Hood et al., 2014); however, as demonstrated in this study, a 
bidirectional relationship between glycemic control and HRQoL may be a better explanation for 
this interaction.  
 In the overall model, glycemic control and executive functioning were found to 
significantly and negatively covary with one another, indicating that as one variable increased, 
the other decreased.  These results build on the current research of a significant association 
between glycemic control and executive functioning (Brismar et al., 2007; Guadieri et al., 2008).  
Although adherence was not examined in the current study, past research has also found that 
executive functioning is associated with treatment adherence, as well as glycemic control in type 
1 diabetes (Berg et al., 2007; McNally et al., 2010).  Furthermore, executive functioning has 





control in type 1 diabetes (Smith et al., 2014).  Future research should continue to explore the 
interrelationship of executive functioning and health outcomes in pediatric type 1 diabetes. 
Age, Glycemic Control, and Executive Functioning 
 Additionally, it was hypothesized that age would be associated with glycemic control and 
executive functioning. There were no significant correlations between glycemic control and age 
and age did not significantly predict glycemic control.  These results are inconsistent with 
previous findings that found age to be a significant predictor of glycemic control, with older age 
associated with poorer glycemic control (Acerini et al., 2001; Forga et al., 2015; Levine et al. 
2001).  This discrepancy may be due to the small range of ages (12 to 18-years-of-age) included 
in this study.  A wider range of ages may have provided a greater variation of glycemic control 
and provided more information on the association between these variables. 
On the other hand, child’s age was a significant covariate with child’s sex when 
examining executive functioning.  More specifically, child’s age and sex together were 
significantly associated with self-report Inhibitory Control, but no parent-reported executive 
functioning scales.  As age increased, self-reported inhibition also increased, but these 
associations were small.  These results are somewhat consistent with previous research findings 
that suggest executive functioning improves and develops over time and that age is associated 
with greater executive functioning skills (Anderson, 2002; De Luca et al., 2003).  Once again, 
the limited age range of participants in the study (12 to 18-years-of-age) may have impacted the 
results regarding age. 
When the child’s age was added to the overall model, age did significantly predict 
HRQol, such that younger age was associated with better HRQoL.  Although the model with age 





to the model without child’s age, which was also 95%.  Future studies should include wider age 
ranges, as this may provide a clearer picture of how age impacts glycemic control, executive 
functioning, and HRQoL. 
Sex, Glycemic Control, and Executive Functioning   
Sex was found to be a small, but significant factor in glycemic control and executive 
functioning.  Female sex was associated with more hospitalizations since diagnosis; however, 
sex did not significantly predict glycemic control.  These results are somewhat consistent with 
previous research.  Female sex has been found to be associated with higher levels of HbA1c 
(Hanberger et al., 2008; Samuelsson et al., 2016) and a greater risk of health complications 
resulting from type 1 diabetes (Rohan et al., 2013).  Future research should continue to explore 
how sex impacts glycemic control and health outcomes in type 1 diabetes. 
Regarding executive functioning, sex was only slightly related to Emotion Regulation on 
the self-report CEFI, with males reporting better Emotion Regulation.  Moreover, sex did not 
significantly predict parent or self-report executive functioning.  The current research on the 
association between sex and executive functioning is mixed.  While some research indicates 
females are better at planning and attention (Naglieri & Rojahn, 2001), as well as inhibitory 
control and self-regulation (Yuan et al., 2008), other studies have not found significant 
differences in executive functioning between sexes (Chan, 2001; Hill et al., 2014; Solianik et al., 
2016).  Future research should continue to explore how sex may impact executive functioning. 
Glycemic Control and Executive Functioning 
Consistent with previous research, there were low significant negative correlations 
between glycemic control and executive functioning domains.  More specifically, as HbA1c 





Inhibitory Control, and all parent-reported executive functioning scales decreased.  As the 
number of DKA episodes increased, all parent-reported executive functioning scales decreased, 
but there were no significant correlations with self-report executive functioning.  Increases in the 
number of hospitalizations in the past 6 months were related to decreases in all parent-report 
executive functioning scales, but no self-report executive functioning scales.  Moreover, 
increases in the number of hospitalizations since diagnosis were associated with decreases in all 
parent-reported executive functioning scales and self-report Inhibitory Control and Organization.  
Overall, results indicated that poorer glycemic control was associated with global parent-reported 
executive functioning deficits.  For self-report, only increases in HbA1c and number of 
hospitalizations since diagnosis were associated with lower executive functioning in some 
domains.   
These results are consistent with findings that poor glycemic control is associated with 
deficits in attention (Cameron et al., 2014; Cato et al., 2014; Lin et al., 2010; Nguyen et al., 
2010), working memory (Cameron et al., 2014; Lin et al., 2010; Nguyen et al., 2010; Shehata & 
Eltayeb, 2010), planning (Northam et al., 2001; Primozic et al., 2011; Rasmussen et al., 2011), 
emotion and self-regulation (Glasgow et al., 2007; Graziano et al., 2011; Hughes et al., 2012; 
Rohan et al., 2011), problem-solving (Glasgow et al., 2007; Hills-Briggs & Gemell, 2007), and 
inhibition (Rovet & Alvarez, 1997).  The discrepancy in results based on self- and parent-report 
highlights the importance of gathering data from both youth and their caregivers, rather than 
relying on one source of information. 
Glycemic Control and HRQoL 
 The association between HRQoL and glycemic control was also examined.  Small 





as well as parent-reported Psychosocial, Physical, and overall HRQoL were found.  As HbA1c 
increased (poorer glycemic control), HRQoL decreased.  Additionally, there were small 
significant negative correlations between the number of DKA episodes and all self- and parent-
report HRQoL, whereby an increase in DKA episodes resulted in a decrease in Physical, 
Psychosocial, and Total HRQoL.  Moreover, there were significant negative correlations 
between the number of hospitalizations since diagnosis and number of hospitalizations in the 
past 6 months with both parent and self-report Physical, Psychosocial, and Total HRQoL.  
Increases in the number of hospitalizations since diagnosis and over the past 6 months were 
associated with decreases in HRQoL.  The negative relationships between glycemic control and 
HRQoL were consistent with findings that glycemic instability contributes to physical, 
psychosocial, and overall decreases in HRQoL (Delamater, 2009; Graue et al., 2004; Hood et al., 
2011; Penckofer et al., 2012).  Conversely, good glycemic control has been found to be 
associated with better quality of life in most studies (Hoey et al., 2001; Reid et al., 2013).   
Executive Functioning and HRQoL 
Finally, there were medium significant positive correlations between all parent and self-
report executive functioning domains and all self and parent-reported HRQoL scales (Physical 
Health Summary scores, Psychosocial Health Summary scores, and Total Scale scores).  As 
executive functioning increased, physical, psychosocial, and overall HRQoL also increased.  
Additionally, executive functioning was found to significantly predict self-reported HRQoL and 
had a small effect size.  This model accounted for 78% of the overall variance, with increases in 
executive functioning predicting increases in HRQoL.  When glycemic control was included in 





95% of the variance explained.  Additionally, executive functioning was found to significantly 
and positively covary with parent and self-report HRQoL. 
On the other hand, the models of executive functioning predicting total HRQoL scores 
and parent-report HRQoL, without the inclusion of glycemic control, were not a good fit for the 
data.  These models indicated that glycemic control may need to be included to explain the 
association between executive functioning and parent-report HRQoL.  Conversely, there is a 
significant association between executive functioning and self-report HRQoL regardless of the 
inclusion of information about glycemic control.  These findings may be related to the fact that 
parent-report executive functioning had more correlations with glycemic control compared to 
self-report executive functioning and glycemic control.  These results highlight the importance of 
gathering both parent and youth-report to gain a clearer picture of functioning.   
Overall, these findings are consistent with results indicating an association between lower 
quality of life and deficits in executive functioning in those diagnosed with autism (de Vries & 
Geurts, 2015), multiple sclerosis (Grech et al., 2015), benign tumors (Laffond et al., 2011), 
traumatic brain injury (Krpan et al., 2007), congenital heart disease (Neal et al., 2015), and 
epilepsy (Sherman et al., 2006). 
Implications for Clinical Practice 
 The findings of this study emphasize the need for health professionals to screen and 
monitor executive functioning, as this variable is associated with glycemic control and HRQoL 
in youth with type 1 diabetes.  Results from this study indicate that executive functioning may be 
able to predict self-report HRQoL in those with type 1 diabetes.  Clinician awareness of patient 
executive functioning may help to identify those who need additional support and intervention.  





HRQoL and treatment in one area may lead to gains in the other areas.  As a result, intervention 
that targets executive functioning may lead to improvements in glycemic control, medical 
outcomes, and patient HRQoL.  Executive functioning interventions and cognitive training have 
shown to be promising in treating those with a traumatic brain injury, stroke, autism spectrum 
disorder, cognitive decline due to age, and attention-deficit/hyperactivity disorder (Diamond & 
Ling, 2016).   Thus, executive functioning interventions that include techniques such as goal 
setting, organizational strategies, structured planning, overlearning information, monitoring 
outcomes, and modifying approaches to achieve goals may improve medical and psychosocial 
outcomes in those with pediatric type 1 diabetes.   
Limitations and Future Research 
 One of the limitations of the existing study is the missing data for number of DKA 
episodes.  Although the 180 participants who did have information regarding number of DKA 
episodes were included in the analyses, this missing data lead to a decrease in power for some 
analyses.  Additionally, low endorsement of a history of seizures and hypoglycemia meant these 
variables could not be used in the hypothesized analyses and model.  Past research indicates 
seizures and hypoglycemia are related to deficits in overall executive functioning (Graveling et 
al., 2015; Ryan et al., 1990) and more specifically attention (Bjorgaas et al., 1997; Cato et al, 
2014; Hannonen et al, 2008; Rovet & Alvarez, 1997; Rovet & Ehrlich, 1999), problem solving 
(Asvold et al., 2010), working memory (Hannonen et al., 2008; Lin et al., 2010; Sommerfield et 
al., 2003), and planning (Ly et al., 2011).  Although this study did find significant associations 
between glycemic control and executive functioning, these correlations were small.  The addition 






 An additional limitation of the study was the restricted age-range.  Participants had to be 
between ages 12 to 18 to participate in the study and this age-limit was set due to the age 
requirement for the self-report CEFI (12-years-old).  Inclusion of younger participants may have 
given more information about how age impacts glycemic control and executive functioning, as 
age was not found to be a significant predictor for these domains.  Future studies should include 
a wider age range to gain a clearer picture of the interrelationship between age, glycemic control, 
and executive functioning. 
 Another limitation in this study was the use of self and parent-report measures of 
executive functioning only, rather than tests that ask the participants to directly perform tasks of 
executive functioning.  Self and parent-reports of executive functioning can be impacted by 
perception and may not provide the best picture of actual executive functioning.  Inclusion of 
tasks of executive functioning may have provided more detailed and accurate information of 
participant executive functioning.  Additionally, the lack of teacher-report hinders the 
opportunity for more diverse viewpoints of the participant’s executive functioning.  Tasks at 
school are more cognitively demanding, and therefore, teacher input may have provided a more 
accurate perception of the participant’s executive functioning.  Future studies should consider 
including tasks of executive functioning and teacher-report of executive functioning in their 
research design. 
 In the future, research should continue to examine the factors that contribute to glycemic 
control, medical outcomes, and HRQoL.  As youth survive with type 1 diabetes into adulthood, it 
is essential health care providers are aware of the variables that can contribute to optimal 
outcomes and better quality of life.  Furthermore, future research should focus on exploring how 





those with a chronic medical condition.  Executive functioning interventions have shown 
promise in remediating cognitive deficits in those with other chronic medical conditions, and 
future research should explore the potential impact of executive functioning interventions on 

























SUMMARY AND CONCLUSION 
This study adds to the current research on quality of life, executive functioning, and 
glycemic control in pediatric type 1 diabetes.  Although manty studies have focused on executive 
functioning and glycemic control or glycemic control and quality of life, there are few other 
current studies that examine the association between these variables in pediatric type 1 diabetes.  
Results from this study indicate that executive functioning can predict HRQoL in youth with 
type 1 diabetes, and that executive functioning, glycemic control, and HRQoL are interrelated in 
this population.  Future research should continue to focus on the variables that impact medical 
outcomes and HRQoL in youth with chronic illnesses, as well as examine the potential 
effectiveness of executive functioning interventions in ameliorating glycemic instability and poor 
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PedsQL™ 3.2 Diabetes Module Field Test 
Medical Chart Review 
 
Date:  ______   /  ______    / ______ 
                MM        DD            YYYY 
 
Data Collection Site:  ________________________________________________________ 
Participant’s 4 Digit Study ID#:    
 
Primary Diabetes Diagnosis: Please check one 
 Type 1 Diabetes Mellitus 
 
 Type 2 Diabetes Mellitus 
 
Secondary Diagnosis/Diagnoses: Please check “Yes” or “No” for each secondary diagnosis 
 Yes    No  Autoimmune Thyroid Disease - (Circle one: Hypothyroidism/Hyperthyroidism) 
 Yes  No   Celiac Disease 
 Yes  No   Hypertension 
 Yes  No   Nephropathy 
 Yes   No   Dyslipidemia 
 Yes   No   ADHD                        
 Yes   No   Asthma 
 Yes   No  Autism Spectrum Disorder 
 Yes   No  Intellectual Disability 
 Yes   No   Other: ___________________________________________________________ 
 
Date of Diabetes Diagnosis:    _________ / ______  OR Time Since Diagnosis: _________________________ 
 
                                                    (Month)         (Year)      (Years and months) 
 
Does the patient currently use an insulin pump? Please check one:    Yes    No 
 
Does the patient currently use Continuous Glucose Monitoring (CGM)? Please check one:    Yes    No 
 
Most Recent Hemoglobin A1c Level (HbA1c):    
 
Value  ________ %  Normal range ________  %      
 
Date: ______   /  ______    / ______        
   MM        DD            YYYY      
 
Most Recent BMI: 
    Value  ________  Percentile ________  % 
 
 Date: ______   /  ______    / ______ 






In the past 6 months how many times was the patient seen in an Urgent Care Center, Emergency Department, 
and/or required hospitalization because of his/her diabetes?  
Please circle one: 0              1              2              >3 Unknown 
What was the problem (check all that apply)? 
           Ketones      Diabetic ketoacidosis (DKA)      Hypoglycemia (low blood sugars)      Seizure 
 
           Other: _____________________________________________________________    Unknown 
Since the patient was diagnosed with diabetes, how many times was the patient seen in an Urgent Care Center, 
Emergency Department, and/or required hospitalization because of his/her diabetes? 
Please circle one: 0              1              2              >3 Unknown 
What was the problem (check all that apply)? 
           Ketones      Diabetic ketoacidosis (DKA)      Hypoglycemia (low blood sugars)      Seizure 
 
           Other: _____________________________________________________________    Unknown 
Has the patient experienced diabetic ketoacidosis (DKA) since being diagnosed with diabetes (circle one)?  
a. Yes (if yes, how many times?) ___        b. No        c. Unknown      
